ࡱ>  bjbj-- DOOR R 8lxj0v$=xxxxxxx$z}b:xQQQ:xOxKjKjKjQxKjQxKjKjlmqV:9.mxex0xm~g0~mm~mT QQKjQQQQQ:x:x'i$QQQxQQQQ~QQQQQQQQQR r: CURRICULUM VITAE DAVID L. COHN, M.D. PLACE OF BIRTH: Chicago, Illinois; United States CONTACT INFORMATION: Business Address: Denver Public Health 605 Bannock St. Denver, Colorado 80204 Telephone: (303) 602-8710 Fax: (303) 602-8754 Email:  HYPERLINK "mailto:david.cohn@dhha.org" david.cohn@dhha.org EDUCATION: B.A. - University of Michigan, Ann Arbor, Michigan (Cum Laude) 1967-1971 M.D. - University of Illinois Abraham Lincoln School of Medicine, 1971-1975 Chicago, Illinois POST GRADUATE TRAINING: Internship: Internal Medicine, University of Wisconsin Hospitals, Madison, Wisconsin 1975-1976 Residency: Internal Medicine, University of Wisconsin Hospitals, Madison, Wisconsin 1976-1978 Fellowship: Infectious Diseases, University of Colorado Health Sciences Center, Denver, Colorado 1979-1981 MEDICAL LICENSURE: Wisconsin 1976 Colorado 1979 CERTIFICATION: National Board of Medical Examiners 1976 American Board of Internal Medicine 1978 Infectious Diseases 1982 PROFESSIONAL POSITIONS: Emergency room physician, Methodist Hospital, Madison, Wisconsin 1976-1978 Contract physician, Adult Medicine, Eastside Neighborhood Health 1979-1981 Center, Denver Department of Health and Hospitals Contract physician, Walk-in Clinic, Denver General Hospital, 1979-1981 Denver Department of Health and Hospitals Assistant Director, Disease Control Service, Department of Public 1981-1987 Health, Denver Department of Health and Hospitals Director, Denver Metro Tuberculosis Clinic, Disease Control 1981-1990 Service, Department of Public Health, Denver Department of Health and Hospitals Attending physician, Department of Internal Medicine, Division of 1981-2011 Infectious Diseases, Denver General Hospital, Denver Health Medical Center Coordinator, AIDS Activities, Disease Control Service, 1982-1989 Department of Public Health, Denver Department of Health and Hospitals Director, Disease Control Service, Department of Public Health, 1987-1996 Denver Department of Health and Hospitals Associate Director, Department of Public Health, Denver Department 1989-2011 of Health and Hospitals Acting Director, Department of Public Health, Denver Department of 1990-1991 Health and Hospitals Acting Chief, Division of Infectious Diseases, Denver General Hospital 1990-1991 Director, Communicable Disease Control, Department of Public Health 1996-2011 Director, HIV/AIDS Services, Denver Department of Public Health, 2001-2005 Denver Health and Hospital Authority Temporary Advisor, Research and Development Unit, Tuberculosis 1992 Programme, World Health Organization, Geneva, Switzerland Medical Officer, Research and Surveillance Unit, Global Tuberculosis 1994-1995 Programme, World Health Organization, Geneva, Switzerland Consultant, Research and Surveillance Unit, Global Tuberculosis 1995-2001 Programme, World Health Organization, Geneva, Switzerland Attending physician (volunteer), Infectious Diseases Clinic, Center for 2011-present Positive Health, Department of Public Health, Denver Health and Hospital Authority Training Director, Ebola Treatment Centre, International Medical Corps, 2015 Lunsar, Sierra Leone Interim Chief, Division of Infectious Diseases, Department of Medicine, 2015-2016 Denver Health Medical Center, Denver Health and Hospital Authority Medical Consultant. Emergency Food and Medical Assistance Project for 2019-present Venezuela, Pan American Development Foundation ACADEMIC AND TEACHING APPOINTMENTS: Department of Medicine, Division of Infectious Diseases, University of Colorado Health Sciences Center (School of Medicine) Instructor 1981-1983 Assistant Professor 1983-1988 Associate Professor 1988-1996 Professor 1996-present Faculty, Centers for Disease Control and Prevention, Sexually Transmitted 1981-2011 Diseases Regional Training Center Faculty, Clinical Management and Control of Tuberculosis, 1981-present Denver TB Course, National Jewish Health Visiting Professor, Novel Education Clinical Trainees and Researchers 2011-2015 (NECTAR)Program, University of Zimbabwe College of Health Sciences Affiliated Faculty, Center for Global Health, University of Colorado 2011-present School of Public Health PROFESSIONAL ORGANIZATIONS AND SOCIETIES: American College of Physicians Associate 1975-1981 Member 1981-1986 Fellow 1986-2019 American Society for Microbiology 1981-2011 American Venereal Disease Association 1981-2011 American Thoracic Society 1981-present Colorado Trudeau Society 1982-1990 Colorado Public Health Association 1982-2010 Infectious Diseases Society of America (IDSA) Member 1984-1996 Fellow 1996-present International AIDS Society 1987-present Physicians Association for AIDS Care 1988-2011 Western Society for Clinical Investigation 1992-2004 International Union Against Tuberculosis and Lung Disease 1994-2018 Colorado Chapter, IDSA 2007-present COMMITTEES AND OFFICES HELD (Member, unless otherwise stated): Pharmacy and Therapeutics Committee. Denver General Hospital 1983-1986 Chemotherapy of Tuberculosis. National Consensus Conference on 1984 Tuberculosis. Palm Beach, FL. Nominating Committee. Scientific assembly on microbiology, 1984-1985 tuberculosis, and pulmonary infections. American Thoracic Society Subcommittee on AIDS. Scientific assembly on microbiology, 1985-1989 pulmonary infections, and tuberculosis. American Thoracic Society Co-chair, Subcommittee on improving methods for preventing infection 1985 of the uninfected. Future Research in Tuberculosis: Prospects and Priorities for Elimination. Pittsfield, MA Second workshop on Pulmonary Complication of AIDS. National Heart, 1986 Lung, and Blood Institute. Kansas City, MO Third workshop on Pulmonary Complications of AIDS. National Heart, 1986 Lung, and Blood Institute. San Francisco, CA Program Committee. Scientific assembly on microbiology, 1986-1989 tuberculosis, and pulmonary infections. American Thoracic Society Secretary, Scientific assembly on microbiology, tuberculosis, and 1986-1987 pulmonary infections. American Thoracic Society Program Committee. American College of Physicians - Colorado 1987 Scientific Meeting. Colorado Springs, Colorado Program Committee. NIAID AIDS Conference for Nurses and Social 1987 Workers Denver, Colorado Co-Chair, AIDS Medical Task Force, Denver General Hospital 1987-1988 Co-Chair, HIV Patient Care Task Force, Denver Health and Hospitals 1987-1989 Biosafety Committee. University of Colorado Health Sciences Center 1987-1989 Steering Committee. Denver Health and Hospitals HRSA AIDS Service 1988-1992 Demonstration Project Colorado Medical Society Task Force on AIDS 1988-1993 Governor's AIDS Coordinating Council 1988-1994 1996-1999 Colorado Department of Health Advisory Body for Elimination of 1989-1990 Tuberculosis Co-Chair, Employee HIV Prevention Task Force. Denver Health and 1990 Hospitals HIV Prevention Committee. Graduate Medical Education. University 1990 of Colorado Health Sciences Center Scientific Program Committee. 6th International Conference on AIDS 1990 San Francisco, CA Chair, HIV Infection in Health Care Workers Task Force. 1990-1991 Denver Health and Hospitals HIV Anonymous Testing Site Evaluation Committee. Colorado Department 1990-1992 of Health and Environment Chair, Mycobacterium avium complex Protocol Team. Terry Beirn Community 1990-1997 Programs for Clinical Research on AIDS. National Institutes of Health Treatment of Tuberculosis Protocol Team. Terry Beirn Community 1992-1997 Programs for Clinical Research on AIDS. National Institutes of Health Clinical Working Group. Workshop on Developing New Treatments for 1992 Tuberculosis. American Thoracic Society, World Health Organization. Washington DC Program Committee. Frontiers in Mycobacteriology: M. avium, the Modern 1992 Epidemic. Vail, CO U.S. Public Health Service Task Force on Prophylaxis and Therapy 1992 for Mycobacterium avium complex Statement Committee on Fungal Infections in HIV-infected Persons. 1990-1995 American Thoracic Society Consultant, Antiviral Drugs Advisory Committee. Food and Drug 1993 Administration Steering Committee. Terry Beirn Community Programs for Clinical 1993-2006 Research on AIDS. National Institutes of Health HIV Resources Planning Council for Title I CARE Act. City and 1993-1994 County of Denver Program Committee. Scientific assembly on microbiology, tuberculosis, 1994-1995 and pulmonary infections. American Thoracic Society Chair, Meeting on the Use of RFLP Analysis for Epidemiologic Studies of 1994 Tuberculosis in Developing Countries. World Health Organization Secretariat, Steering Committee. Clinical Research and Product 1995 Development. Global Programme on AIDS. World Health Organization Secretariat, Steering Committee. Immunology of Mycobacteria. Global 1995 Tuberculosis Programme. World Health Organization Secretariat and Rapporteur, TB/HIV Research Workshop. Global Tuberculosis 1995 Programme. World Health Organization WHO/IUATLD Working Group on Global Antituberculosis Drug Resistance 1995-2000 Surveillance. Global Tuberculosis Programme. World Health Organization. Complications of HIV Subcommittee. Terry Beirn Community Programs for 1995-1998 Clinical Research on AIDS. National Institutes of Health. Board of Directors, American Society for Tuberculosis Research and 1995-2003 Education Rapporteur, Workshop of the WHO/IUATLD Global Working Group on Anti- 1996 tuberculosis Drug Resistance Surveillance. Paris, France Publications and Presentations Committee, Terry Beirn Community Programs 1997-2000 for Clinical Research on AIDS Writing Committee, WHO/IUATLD Antituberculosis Drug Resistance 1997 Surveillance. World Health Organization Long Range Planning Committee, Scientific assembly on microbiology, 1997-2000 tuberculosis, and pulmonary infections. American Thoracic Society Co-Chair, Working Group on Preventive Therapy for TB in HIV-Infected 1997 Patients, Conference on HIV-Associated Tuberculosis. Centers for Disease Control and Prevention Rapporteur, Meeting on TB Preventive Chemotherapy in People Living with 1998 HIV/AIDS. World Health Organization, Geneva, Switzerland American Thoracic Society Chair, ATS/CDC Statement Committee on Targeted 1998-2000 Tuberculin Testing and Treatment of Latent Tuberculosis Infection Co-Chair, bis-POM Protocol Team, Terry Beirn Community Programs for Clinical Research on AIDS, National Institutes of Health 1998-2000 Chair, Workgroup on International Audiences, Strategic Plan for 1998 Tuberculosis Training and Education Summit Meeting, Oakland, CA Science Planning Committee. Terry Beirn Community Programs for 1998-2000 Clinical Research on AIDS. National Institutes of Health. Implementation Committee, Strategic Plan for Tuberculosis Training and 1998-2001 Education. Model Tuberculosis Centers, Centers for Disease Control and Prevention. Tuberculosis Committee, Infectious Diseases Society of America 1998-2001 Advisory Council for the Elimination of Tuberculosis, Centers 1998-2002 for Disease Control and Prevention Exercise TOPOFF, Simulated Bioterrorism attack (Plague), Denver 2000 Chair, Nominating Committee. Scientific assembly on microbiology, 2000-2001 tuberculosis, and pulmonary infections. American Thoracic Society Chair, Planning Committee. HIV/AIDS Care in Safety Net Systems: Current 2000-2001 and Future Challenges Colorado Advisory Council on AIDS 2000-2001 National Advisory Committee. Healthy Ways, STD/HIV Prevention 2000-2003 Research in 2 American Indian Tribes. Chair, Science Planning Committee. Terry Beirn Community Programs for 2000-2006 Clinical Research on AIDS. National Institutes of Health. Chair, Planning Committee, Scientific assembly on microbiology, 2001-2003 tuberculosis, and pulmonary infections. American Thoracic Society Executive Committee, Internal Advisory Committee, Center for AIDS Research. 2001-2006 University of Colorado Health Sciences Center SMART Protocol Team, Terry Beirn Community Programs for Clinical Research 2001-2007 on AIDS Global TB/HIV Working Group (Core Group), Stop TB Department, World Health 2001-2004 Organization Planning Committee, 4th World Congress on Tuberculosis 2002 Medical Expert, Mayor Wellington Webb's Denver Trade and Partnership 2002 Mission to South African Development Community Task Force on MRSA (Methicillin Resistant S. aureus) in School/Child 2002 Care Recommendations. Colorado Department of Public Health and Environment Instructor, Adult HIV/AIDS Treatment, MTCT (Mother to Child Transmission)- 2003-2004 Plus Training Program, Eldoret and Kisumu, Kenya Disaster Group, Rocky Mountain Center for Medical Response to 2003-2011 Terrorism, Mass Casualties and Epidemics, Denver Health Developmental Grant Review Committee, Center for AIDS Research, 2003-2007 University of Colorado Health Sciences Center ATS Representative, ATS/CDC Meeting on Hepatotoxicity of Rifampin/Pyrazinamide 2003 Therapy for Latent Tuberculosis Infection, Seattle, WA Chair, Scientific assembly on microbiology, tuberculosis, and pulmonary 2004-2006 Infections, American Thoracic Society Board of Directors, American Thoracic Society 2004-2006 ATS Representative, Global TB/HIV Working Group, Stop TB Department, 2004-2011 World Health Organization Public Health Leaders in Clinical Research Working Group, 2005-2007 TB Trials Network, NIH Roadmap Initiative Advisory Committee, Body Worlds-2: The Anatomical Exhibition of 2005-2006 Real Human Bodies. Denver Museum of Nature and Science Emerging Infectious Diseases Task Force, Denver Health 2005-2010 Chair, CPCRA Science Committee, Terry Beirn Community Programs for 2006-2010 Clinical Research on AIDS. National Institutes of Health Executive Committee, International Network for Strategic Initiatives 2006-2010 in Global HIV Trials (INSIGHT). National Institutes of Health Reviewer, International Standards for Tuberculosis Care 2006, 2009 Mentor and Consultant, International Center for AIDS Care and Treatment 2006-2007 Programs (ICAP), Columbia University, Central Province, Kenya Facilitator, External Scientific Review, Tuberculosis Trials Consortium. 2007 Centers for Disease Control and Prevention Mycobacterium avium complex Writing Group, DHHS-IDSA Guidelines for 2007, 2010 the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults Health Policy Committee. American Thoracic Society 2007-2010 ATS/CDC/IDSA Statement Committee on Diagnostic Standards and 2007-2017 Classification of Tuberculosis in Adults and Children Team Leader, Bio-Surveillance Task Force, Democratic National Convention, 2008 Denver Board of Directors, Colorado Chapter, Infectious Diseases Society of 2007-2012 America Data and Safety and Monitoring Committee, Evaluation of the Impact of 2008-2012 Early Initiation of HAART on TB Treatment Outcomes in TB Patients Co-infected with HIV (TB-HAART Study), Special Programme for Research and Training in Tropical Diseases (TDR). World Health Organization Optimization of Co-Infection and Co-Morbidity Management (OpMAN) 2008-2010 Scientific Committee, AIDS Clinical Trials Group Consultant, Policy Guidelines on Improving Health Workers Access to 2009-2010 Prevention, Treatment and Care Services for HIV and TB. World Health Organization Peer Review Committee, Priority Research Questions for TB/HIV in 2009-2010 HIV-prevalent and Resource-limited Settings, TB/HIV Working Group. World Health Organization Continuing Medical Education Advisory Committee, STD/HIV Prevention and 2009-present Training Center. Denver Public Health Influenza H1N1 Vaccine Task Force, Denver Health 2009-2010 Hepatotoxicity Working Group, Tuberculosis Trials Consortium, CDC 2009-2016 Chair, External Review Committee, Integrated Management of Adolescent and 2011 Adult Illness (IMAI) District Clinician Manual: Hospital Care for Adolescents and Adults. HIV Department, World Health Organization LTBI Guidelines Working Group, ATS/CDC/IDSA 2011-2016 LTBI Treatment Protocol Team, Tuberculosis Trials Consortium, CDC 2012-2016 Chair, TB Research Working Group, NECTAR Program, University of Zimbabwe 2012-2015 College of Health Sciences TBTEAM, World Health Organization 2012-2018 ID Fellowship Research Advisory Committee, Division of Infectious Diseases, 2012-present University of Colorado Denver School of Medicine Chair, Data and Safety and Monitoring Board, Prospective, Randomized, 2013-present Blinded Phase 2 Pharmacokinetic/Pharmacodynamic Study of the Efficacy and Tolerability of Levofloxacin in Combination with Optimized Background Regimen (OBR) for the treatment of MDR-TB (Opti-Q Study).  HYPERLINK "https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&ved=0CC4QFjAA&url=http%3A%2F%2Fwww.niaid.nih.gov%2FABOUT%2FORGANIZATION%2FDMID%2FPages%2Fdefault.aspx&ei=hdenUrCeIYaiqQGk-YHAAg&usg=AFQjCNEXhRZTNjyvOtiVs3G5fNLH0T7Rqg&sig2=vfL8N9DBWaC7iEp0taz5lQ&bvm=bv.57799294,d.aWM" Division of Microbiology and Infectious Diseases, National Institutes of Health MTPI Assembly Awards and Recognition Working Group, American Thoracic Society 2013-2015 START Study - TB Writing group, International Network for Strategic 2015-2017 Initiatives in Global HIV Trials (INSIGHT)\ LTBI Treatment Guidelines Writing Group, NTCA/CDC 2017-present Documents Development and Implementation Committee, American Thoracic 2017-present Society GRANT AND CONTRACTS (Principal or Co-Principal Investigator): AIDS Surveillance and Epidemiologic Investigations in the State of Colorado. Percent effort 5-10%. Project periods: 1984-86, 1987-89, 1990-92, 1993-96, 1997-99, 2000-03, 2004-06, 2007-09, 2010-12. Centers for Disease Control and Prevention, through Colorado Department of Health and Environment. Community Based Demonstration Project for AIDS Prevention and Risk Reduction. Percent effort 15-30%. Project periods: 1985-89, 1989-94. Centers for Disease Control and Prevention. Prospective Double Blind Study of Zidovudine in the Treatment of Patients with Early HIV-Associated Immunodeficiency. Percent effort 20%. Project period 1987-1989. Fitzsimons Army Medical Center, Burroughs-Wellcome Co. AIDS Services Demonstration Project. Percent effort 3%-5%. Project period 1989-1992. Health Resources Services Administration. Expanded Initiatives and the Evaluation of Surveillance of AIDS and HIV Infection: Adult Spectrum of Disease. Percent effort 5%. Project periods: 1989-1992, 1992-1996, 1997-1999, 2000-2004. Centers for Disease Control and Prevention. HIV Seroprevalence in a Homeless Population. Percent effort 5%. Project period: 1990-1992. Centers for Disease Control and Prevention. Terry Beirn Community Programs for Clinical Research of AIDS (CPCRA). Percent effort 25%-40%. Project periods: 1989-94, 1994-1999, 2000-2007. National Institute of Allergy and Infectious Diseases, National Institutes of Health. Division of AIDS Treatment Research Initiative (DATRI). Percent effort 5%. Project period: 1992-1996. National Institutes of Health. Tuberculosis Trials Consortium (TBTC). Percent effort 1%. Project periods: 1994-1999, 2000-2009, 2010-2019. Centers for Disease Control and Prevention. International Network for Strategic Initiatives in Global HIV Trials (INSIGHT). Percent effort 40%. Project period: 2006-2011. National Institute of Allergy and Infectious Diseases, National Institutes of Health. Community Programs for Clinical Research on AIDS Clinical Trials Unit, AIDS Clinical Trials Group (ACTG). Percent effort 20%. Project period: 2007-2012. National Institute of Allergy and Infectious Diseases, National Institutes of Health. AIDS Malignancy Consortium. Percent effort 5%. Project period 2008-2011. National Cancer Institute, National Institutes of Health. PEER REVIEWER FOR JOURNALS: American Journal of Public Health, American Journal of Respiratory and Critical Care Medicine, American Review of Respiratory Diseases, AIDS, Annals of Internal Medicine, Archives of Internal Medicine, BMC Infectious Diseases, Chest, Clinical Infectious Diseases, Emergindex, International Journal of Tuberculosis and Lung Disease, Journal of the American Medical Association, Journal of Infectious Diseases, Lancet, Medical Letter, New England Journal of Medicine, Respiratory Medicine, Reviews of Infectious Diseases, Tubercle and Lung Disease EDITORIAL BOARDS: Infectious Disease News 2003-present Pulmonary Reviews 2008-2012 HONORS AND AWARDS: Chicago Tribune Outstanding Senior Award 1967 William J. Branstrom Award for Academic Excellence, University of Michigan 1968 Phi Eta Sigma National Honorary 1968 Colorado AIDS Project Appreciation Award 1985 Leadership Denver 1987-1988 Best Poster Presentation, National STD Meeting, Atlanta 1987 Honorary Board Member, Colorado AIDS Project 1987 Honorary Committee, "Put It On Ice" AIDS Fundraiser 1988 U.S. Department of Health and Human Services Regional Director's 1988 Citation for AIDS/HIV Research and Prevention Denver Health and Hospitals Junior Faculty Scholarly Achievement Award 1991 Hero in the AIDS Epidemic, Colorado AIDS Project 1992 Top Docs in Denver, 5280 Magazine 1993-1995, 1998 International Who's Who 1996 Best Doctors in America: Central Region 1996-1998 Who's Who in Medicine and Health Care 1997-1998 Who's Who in the World 1997-1999 Colorado AIDS Project Leadership Recognition Award 1997 Outstanding Educator Award, Infectious Diseases Division, 1998-1999 University of Colorado Health Sciences Center Strathmore's Who's Who 1999-2000 Life Member - National Registry of Who's Who 2001 American's Registry of Outstanding Professionals 2001-2002 Best Doctors in America 2002, 2003, 2006, 2011 Outstanding Educator Award, Infectious Diseases Division, 2002-2003 University of Colorado Health Sciences Center Americas Top Doctors 2004, 2005, 2007-2009 Leading Physicians of the World 2013, 2016 Patent Safety and Quality Pillar Award, High Risk Infection Team 2015 (Ebola preparedness plan), Denver Health Outstanding Volunteer Award, Denver Health Medical Staff 2015 Professional Whos Who 2018 PUBLICATIONS: Journal Articles: Bundtzen RW, Gerber AU, Cohn DL, Craig WA. Postantibiotic suppression of bacterial growth. Rev Infect Dis 1981;3:28-37. Cohn DL, Reimer LG, Reller LB. Comparative in-vitro activity of MK0787 (N-formimdoyl thienamycin) against 540 blood culture isolates. J Antimicrob Chemother 1982;9:183-194. Cohn DL, Judson FN. Genital mycoplasmas. Med Aspects Human Sexuality 1983;17:196-204. Judson FN, Sbarbaro JA, Tapy JM, Cohn DL. Tuberculosis screening: evaluation of a food handlers' program. Chest 1983;83:879-82. Ellison RT, Judson FN, Peterson LC, Cohn DL, Ehret JM. Oral rifampin and trimethoprin/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections. West J Med 1984;140:735-40. Judson FN, Lince DM, Anders BJ, Tapy JM, LeVan D, Cohn DL, Kicera TJ. Health status of Southeast Asian refugees in Denver. West J Med 1984;141:183-8. Kirkpatrick CH, Davis KC, Horsburgh Jr CR, Cohn DL, Penley K, Judson FN. Interleukin-2 production by persons with the generalized lymphadenopathy syndrome or the acquired immune deficiency syndrome. J Clin Immunol 1985;5:31-7. Snider DE, Cohn DL, Davidson PT, Hershfeld ES, Smith MH, Sutton FD. Standard therapy for tuberculosis. Chest 1985;87:117S-24S. Ryder JW, Croen K, Kleinschmidt-DeMasters BK, Ostrove JM, Straus SE, Cohn DL. Progressive encephalitis three months following resolution of cutaneous zoster in an AIDS patient. Ann Neurol 1986;19:182-8. Blaser MJ, Cohn DL. Opportunistic infections in patients with the acquired immune deficiency syndrome: clues to the epidemiology of AIDS and relative virulence of pathogens. Rev Infect Dis 1986;8:21-30. Dobozin BS, Judson FN, Cohn DL, Penley KA, Rickman PE, Blaser MJ, Sarin PS, Weiss SH, Kirkpatrick CH. The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men. Cell Immunol 1986;98:156-71. Sharma OK, Buschman FL, Borek E, Cohn DL, Penley KA, Judson FN, Dobozin BS, Horsburgh Jr CR, Kirkpatrick CH. Altered excretion of modified nucleosides and B-aminoiso-butyric acid in subjects with AIDS or at risk for AIDS. Cancer Res 1986;46:2557-61. Sbarbaro JA, Cohn DL, Crowle AJ, Glassroth J, Goren MB, Lane JM, Liang A, Miller AE, Pickett MJ, Riley RL, Smith DW, Sullivan MA. Improving methods for preventing infection of the uninfected. Supplement on future research in tuberculosis: prospects and priorities for elimination. Am Rev Respir Dis 1986;134:407-9. Blaser MJ, Cohn DL, Cody MJ, Penley KA, Judson FN, Saxinger WC, Weiss SH. Counter immunoelectrophoresis for detection of human serum antibody to HTLV-III. J Immunol Methods 1986;91:181-6. Horsburgh Jr CR, Cohn DL, Roberts RB, Masur H, Miller RA, Tsang AY, Iseman MD. Mycobacterium avium-intracellulare isolates from AIDS patients differ from isolates from patients without AIDS. Antimicrob Agents Chemother 1986;30:955-7. O'Brien RJ, Miller B, Pitchenik AE, Reichman LB, Bloch AB, Hopewell PC, Cohn DL. Topics in pulmonary medicine: Mycobacterial diseases in AIDS. Am Rev Respir Dis 1987;136:1027-30. Ward JW, Holmberg SD, Allen JR, Cohn DL, Critchley SE, Kleinmen SH, Lenes BA, Ravenholt O, Davis JR, Quinn MG, Jaffe HW. Human immunodeficiency virus transmission by blood transfusions screened negative for HIV antibody. N Engl J Med 1988;318:473-8. Rector WG, Govindarajan S, Horsburgh CR, Penley KA, Cohn DL, Judson FN. Hepatic inflammation, hepatitis B replication, and cellular immune function in homosexual men with chronic hepatitis B and antibody to human immunodeficiency virus. Am J Gastroenterol 1988;83:262-6. Rietmeijer CAM, Cohn DL. Severe contact dermatitis from dinitrochlorobenzene. Arch Dermatol 1988;124:490-1. Perlman DM, Ampel NM, Schifman RB, Cohn DL, Patton CM, Aguirre ML, Wang WL, Blaser MJ. Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus. Ann Intern Med 1988;108:540-6. Janoff EN, Douglas JM, Gabriel M, Blaser MJ, Davidson AJ, Cohn DL, Judson FN. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1. J Infect Dis 1988;158:983-90. O'Brien RF, Quinn JL, Miyahara BT, Lepoff RB, Cohn DL. Diagnosis of Pneumocystis carinii pneumonia by induced sputum in a city with moderate incidence of AIDS. Chest 1989;95:136-8. Crowle AJ, Cohn DL, Poche PA. Defects in sera from AIDS patients and non-AIDS patients with Mycobacterium avium infection, which decrease macrophage resistance to M. avium. Infect Immun 1989;57:1445-51. Hoffman RE, Valway SE, Wolf FC, Raevsky C, Cohn DL, Penley KA, Vernon TM. Comparison of AIDS and HIV antibody surveillance data in Colorado. J Acquir Immun Defic Syndrome 1989;2:194-200. Rietmeijer CAM, Penley KA, Cohn DL, Davidson AJ, Horsburgh CR, Judson FN. Factors influencing the risk of infection with human immunodeficiency virus in homosexual men - Denver 1982-1985. Sex Trans Dis 1989;16:95-102. Cohn DL. Pulmonary infections in AIDS. Sem Respir Med 1989;10:1-11. O'Brien RF, Cohn DL. Seroganguineous pleural effusions in AIDS-associated Kaposi's sarcoma. Chest 1989;96:460-6. Perez-Perez GI, Cohn DL, Guerrant RL, Patton CM, Reller LB, Blaser MJ. Clinical and immunological significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in the United States. J Infect Dis 1989;160:460-8. Polish LB, Cohn DL, Ryder JW, Myers AM, O'Brien RF. Pulmonary non-Hodgkin's lymphoma in AIDS. Chest 1989;96:1321-6. Cohn DL, Catlin BJ, Peterson KL, Judson FN, Sbarbaro JA. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: A twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med 1990;112:407-15. Payne TH, Cohn DL, Davidson AJ, Henry TD, Schaefer JW, Gabow PA. Marked elevations of serum alkaline phosphatase in patients with AIDS. J Acquir Immun Defic Syndr 1991;4:238-43. Lee BY, Chatterjee D, Bozic CM, Brennan PJ, Cohn DL, Bales JD, Harrison SM, Andron LA, Orme IM. Prevalence of serum antibody to the type-specific glycopeptidolipid antigens of Mycobacterium avium in HIV-positive and HIV-negative individuals. J Clin Micro 1991;29:1026-9. McClellan MD, Miller SB, Parsons PE, Cohn DL. Incidence and clinical characteristics of pneumothorax with Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Chest 1991;100:1224-8. Blum RN, Miller LA, Gaggini LC, Cohn DL. Comparative trial of dapsone versus trimethoprim-sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia. J Acquir Immun Defic Syndr 1992;5:341-7. Farizo KM, Buehler JW, Chamberland ME, Whyte BM, Froelicher ES, Hopkins SG, Reed CM, Mokotoff ED, Cohn DL, Troxler S, Phelps AF, Berkelman RL. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992;267:1798-1805. Crowle AJ, Ross ER, Cohn DL, Gilden J, May MH. Comparison of the abilities of Mycobacterium avium and Mycobacterium intracellulare to infect and multiply in cultured human macrophages from normal and HIV-infected subjects. Infect Immun 1992;60:3697-3703. Fishbein M, Chan DKS, O'Reilly K, Schell D, Wood R, Beeker R, Cohn D. Attitudinal and normative factors as determinants of gay men's intentions to perform AIDS-related sexual behaviors: a multisite analysis. J Appl Soc Psychol 1992;22:999-1011. Schnell DJ, Higgins D, Wilson RM, Goldbaum G, Cohn DL, Wolitski RJ. Men's disclosure of HIV test results to male primary sex partners. Am J Public Health 1992;82: 1675-6. Rietmeijer CAM, Davidson AJ, Foster C, Cohn DL. Cost of care of HIV infection: patterns of utilization and charges in a public health care system. Arch Intern Med 1993:153:219-25. Schnell DJ, Galavotti C, O'Reilly KR, AIDS Community Demonstration Projects (Freeman A, Cohn D, Corby N, Wood R). An evaluation of sexual behavior change using statistical and cognitive models. Statist Med 1993;12:219-27. Blum RN, Polish LB, Tapy JM, Catlin BJ, Cohn DL. Results of screening for tuberculosis in foreign-born persons applying for adjustment of immigration status. Chest 1993;103:1670-4. Cohn DL, Dobkin JF. Treatment and prevention of tuberculosis in HIV infection. AIDS 92-93: - A Year in Review 1993:7(suppl 1):S195-S202. Nightingale SD, Cameron DW, Gordin FM, Sullam PM, Cohn DL, Chaisson RE, et al. Two placebo controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;329:828-33. Masur H, Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium complex. Recommendations on prophylaxis and therapy for Mycobacterium avium complex in patients infected with human immunodeficiency virus. N Engl J Med 1993;329:898-904. Bessesen MT, Shlay JC, Stone-Venohr B, Cohn DL, Reves RR. Disseminated Mycobacterium genevense infection in AIDS: clinical and microbiological features and response to therapy. AIDS 1993;7:1357-61. Cohn DL, Iseman MD. Treatment and prevention of multidrug-resistant tuberculosis. In: Rastogi N, ed, Emergence of multiple drug-resistant tuberculosis: fundamental and applied research aspects, global issues, and current strategies. Res Microbiol 1993;144:150-3. Safrin S, Kemmerly S, Plotkin B, Smith T, Weissbach N, DeVeranez D, Phan LD, Cohn DL. Foscarnet-resistant herpes simplex virus infection in patients with the acquired immunodeficiency syndrome. J Infect Dis 1994;169:193-6. Stone BL, Cohn DL, Kane MS, Hildred MV, Wilson ML, Reves RR. Utility of paired blood cultures and smears in the diagnosis of disseminated Mycobacterium-avium complex infections in AIDS patients. J Clin Micro 1994;32:841-2. Abrams DI, Goldman AI, Launer C, Korvick JA, Neaton JD, Crane LR, Grodesky M, Wakefield S, Muth K, Kornegay S, Cohn DL, et al. A comparative trial of didanosine and zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. N Engl J Med 1994;330:657-62. Von Roenn JH, Armstrong D, Kotler DP, Cohn DL, Klimas NG, Tehekmedyian NS, Cone L, Brennan PJ, Weitzman SA. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994;121:393-9. Hoxworth T, Hoffman R, Cohn D, Davidson A. Anonymous HIV testing: does it attract clients who would not seek confidential testing? AIDS & Public Policy J 1994; 9:182-9. Burman WJ, Cohn DL, Reves RR, Wilson ML. Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. Clin Infect Dis 1995;20:564-70. Bessessen MT, Miller LA, Cohn DL, Bartlett S, Ellison RT. Administration of pyramethamine sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients with AIDS. Clin Infect Dis 1995;20:730-1. Cohn DL. Treatment of multidrug-resistant tuberculosis. J Hosp Infect 1995;30(suppl):322-8. Rietmeijer CA, Kane SM, Simons PZ, Corby NH, Wolitski RJ, Higgins DL, Judson FN, Cohn DL. Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted community-level HIV prevention program. AIDS 1996;10:291-8. Shlay JC, Blackburn D, O'Keefe K, Raevsky C, Evans M, Cohn DL. Human immunodeficiency virus seroprevalence and risk assessment of a homeless population in Denver. Sex Transm Dis 1996;23:304-11. Simons PZ, Rietmeijer CA, Kane MS, Guenther-Grey C, Higgins DL, Cohn DL. Building a peer network for a community level HIV prevention program among injecting drug users in Denver. Public Health Rep 1996;111(suppl):50-3. Gordin FM, Nelson ET, Matts JP, Cohn DL, Ernst J, Benator D, Besch CL, Crane LR, Sampson JH, Bragg PS, EL-Sadr W, Terry Beirn Community Program for Clinical Research on AIDS. The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. Am J Respir Crit Care Med 1996;154:1478-83. Cohn DL, Bustreo F, Raviglione MC. Drug resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. Clin Infect Dis 1997;24(suppl 1):S121-30. Timpone JG, Wright DJ, Ning L, Egorin MJ, Enama ME, Mayers J, Galetto G, and the DATRI 004 Study Group. The safety and pharmacokinetics of single agent and combination therapy with megesterol acetate and dronabinol for the treatment of HIV-wasting syndrome. AIDS Res Hum Retroviruses 1997;13:305-15. Burman WJ, Reves RR, Rietmeijer CA, Cohn DL. A retrospective comparison of clarithromycin versus rifampin in combination therapy for Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements. Int J Tuberc Lung Dis 1997;2:163-9. Gordin FM, Cohn DL, Sullam PM, Schoenfelder JR, Wynne BA, Horsburgh CR. Early manifestations of disseminated Mycobacterium avium complex disease: a prospective evaluation. J Infect Dis 1997;176:126-32. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly-observed therapy for tuberculosis: epidemiology and effect on the outcome of treatment. Chest 1997;111:1168-73. Cohn DL. Use of BCG vaccination for the prevention of tuberculosis: renewed interest in an old vaccine. Am J Med Sci 1997;313:372-6. Horsburgh CR, Schoenfelder JR, Gordin FM, Cohn DL, Sullam PM, Wynne BA. Geographic and seasonal variation in Mycobacterium avium bacteremia in North American patients with AIDS. Am J Med Sci 1997;313:341-5. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Short-term incarceration for the management of noncompliance with tuberculosis treatment. Chest 1997;112:57-62. Burman WJ, Dalton CB, Cohn DL, Butler JRG, Reves RR. A cost-effectiveness analysis of directly observed therapy versus self-administered therapy for treatment of tuberculosis. Chest 1997;112:63-70. Cohn DL, O'Brien RJ. The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries. Int J Tuberc Lung Dis 1998;2:16-26. Hafner R, Bethel J, Power M, Landry B, Banach M, Mole L, Standiford H C, Follansbee S, Kumar P, Raasch R, Cohn D, Mushatt D, Drusano G. Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in HIV-positive volunteers. Antimicrob Agents Chemother 1998;42:631-9. Gardner LI, Harrison SH, Hendrix CW, Blatt SP, Wagner KF, Chung RCY, Harris RW, Cohn DL, Burke DS, Mayers DL, Military Medical Consortium for Applied Retroviral Research. Size and duration of zidovudine benefit in 1003 HIV-infected patients: US Army, Navy and Air Force natural history data. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:345-53. El-Sadr W, Perlman DC, Matts JP, Nelson ET, Cohn DL, Salomon N, Olibrice M, et al and the Terry Biern Community Programs for Clinical Research on AIDS and the AIDS Clinical Trials Group. Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Clin Infect Dis 1998;26:1148-58. Goldbaum G, Perdue T, Wolitski R, Rietmeijer C, Hedrich A, Wood R, Fishbein M, Cohn D, Corby N, Freeman A, Guenther-Grey C, Sheridan J, Tross S. Differences in risk behavior and sources of AIDS information among gay, bisexual, and straight-identified men who have sex with men. AIDS and Behavior 1998;2:13-21. Clark TM, Burman WJ, Cohn DL, Mehler PS. Septic shock from Mycobacterium tuberculosis after therapy for Pneumocystis carinii. Arch Intern Med 1998;158:1033-5. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Reider HL, Bustreo F, Cohn DL, Lambregts-vanWeezenbeck CSB, Kim SJ, Chaulet P, Nunn P for the WHO/IUATLD Working Group on Anti-tuberculosis Drug Resistance Surveillance. Global sureillance for antituberculosis drug resistance, 1994-1997. N Engl J Med 1998;338:1641-9. Burman WJ, Reves RR, Cohn DL. The case for conservative management of early HIV disease. JAMA 1998;280:93-5. Burman WJ, Stone BL, Rietmeijer CA, Maslow J, Cohn DL, Reves RR. Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithroymycin-based regimen. AIDS 1998;12:1309-15. Reitmeijer CA, Wolitski RJ, Fishbein M, Corby NH, Cohn DL. Sex hustling, injection drug and non-gay identification among men who have sex with men: associations with high-risk sexual behaviors and condom use. Sex Trans Dis 1998;25:353-60. Shlay JC, Chaloner K, Max MB, Flaws B, Reichelderfer P, Wentworth D, Hillman S, Brizz B, Cohn DL. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. JAMA 1998;280:1590-5. Davidson AJ, Bertram SL, Lezotte DC, Marine WM, Rietmeijer CA, Haaglund BB, Cohn DL. Comparison of health status, socioeconomic characteristics and knowledge and use of HIV-related resources between HIV-infected women and men. Med Care 1998;36:1676-84. The CDC AIDS Community Demonstration Projects Research Group. Community-level HIV interventions in five cities: final outcome data from the CDC AIDS Community Demonstration Projects. Am J Pub Health 1999;89:336-45. Gordin FM, Sullam PM, Shafran SD, Cohn DL, Wynne B, Paxton L, Perry K, Horsburgh CR Jr. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated Mycobacterium avium complex. Clin Infect Dis 1999;28:1080-5. Cohn DL, Fisher EJ, Peng GT, Hodges JS, Chesnut J, Child CC, Franchino B, Gibert CL, El-Sadr W, Hafner R, Korvick J, Ropka M, Heifets L, Clotfelter J, Munroe D, Horsburgh CR. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high dose clarithromycin. Clin Infect Dis 1999;29:125-33. Kleinschmidt-DeMasters BK, Mazowiecki M, Bonds LA, Cohn DL, Wilson ML. Coccidioidomycosis meningitis with massive dural and cerebral venous thrombosis and tissue arthroconidia. Arch Pathol Lab Med 2000;124:310-4. Benson CA, Williams PL, Cohn DL, Becker S, Hojczyk P, Nevin T, Korvick JA, Heifets L, Child CC, Lederman MM, Reichman RC, Powderly WG, Notario GF, Wynne BA, Hafner R, ACTG 196/CPCRA 009 Protocol Team. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: a randomized, double-blind, placebo-controlled trial. J Infect Dis 2000;181:1289-97. Burman WJ, Reves RR, Cohn DL, Schooley RT. Breaking the camel's back - multicenter clinical trials and local institutional review boards. Ann Intern Med 2001;134: 152-7. El-Sadr WM, Perlman DC, Nelson E, Matts JP, Cohn DL. A review of efficacy studies of 6-month short-course therapy for tuberculosis among HIV-infected patients: differences in study outcomes. Clin Infect Dis 2001;32:623-32. Hafner R, Bethel J, Standiford HC, Follansbee S, Cohn DL, Polk RE, Mole L, Raasch R, Kumar P, Mushatt D, Drusanoh G, for the DATRI 001B Study Group. Tolerance and pharmacokinetic interactions of rifabutin and azithromycin. Antimicrob Agents Chemother 2001; 45:1572-7. Fisher EJ, Chaloner K, Cohn DL, Grant LB, Alston B, Brosgart CL, Schmetter B, El-Sadr WM, Sampson J, for the Terry Beirn Community Programs for Clinical Research on AIDS. The safety and efficacy of adefovir dipivoxil in persons with advanced HIV disease: a randomized, placebo-controlled trial. AIDS 2001;15:1695-1700. Burman WJ, Terra M, Breese P, Cohn D, Reves R. Lack of toxicity from concomitant directly observed disulfiram and isoniazid-containing therapy for active tuberculosis. Int J Tuberc Lung Dis 2002;6:893-42. Flaks RC, Burman WJ, Gourley PJ, Rietmeijer CA, Cohn DL. HIV transmission risk behavior among persons in HIV care and its relation to treatment adherence. Sex Trans Dis 2003;30:399-403. Bonds LA, Gaido L, Woods JE, Cohn DL, Wilson ML. Infectious diseases detected at autopsy at an urban public hospital: 1996-2001. Am J Clin Pathol 2003;119:866-72. Kaplan JE, Hanson DL, Cohn DL, Karon J, Buskin S, Thompson M, Fleming P, Dworkin MS, and the Adult and Adolescent Spectrum of Disease Group. When to begin highly active antiretorviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte count <350 cells/uL. Clin Infect Dis 2003;37:951-8. Gordin F, Cohn DL, Matts JP, Chaisson RE, OBrien RJ for the Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group and the Centers for Disease Control and Prevention. Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: Is it different than in HIV-uninfected persons? Clin Infect Dis 2004;39:561-5. Dworkin MS, Adams MR, Cohn DL, Davidson A, Buskin S, Horwitch C, Morse A, Sackoff J, Thompson M, Wotring L, McCombs SB, Jones JL. Factors that complicate the treatment of tuberculosis in HIV-infected patients. J Acquir Immune Defic Syndr 2005;39: 464-70. Okwera A, Johnson JL, Luzze H, Nsubuga P, Kayanja H, Cohn DL, Nunn P, Ellner JJ, Whalen CC, Mugerwa RD. Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala. Int J Tuberc Lung Dis 2006;10:39-44. Jenkins TC, Gardner EM, Thrun MW, Cohn DL, Burman WJ. Risk-based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care settings.Sex Transm Dis 2006;33:329-33. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006;355: 2283-96. Dworkin MS, Buskin SE, Davidson AJ, Cohn DL, Morse A, Inungu J, Adams MR, McCombs SB, Jones JL, Moura H, Visvesvara G, Pieniazek NJ, Navin TR. Prevalence of intestinal microsporidiosis in human immunodeficiency virus-infected patients with diarrhea in major United States cities. Rev Inst Med Trop S Paulo 2007; 49:339-42. Kestler MH, Gardner EM, Cohn DL. Hepatic non-Hodgkins lymphoma with lactic acidosis in HIV-infected patients: Report of two cases. JIAPAC 2010; 9:301-05. Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, Jay N, Aboulafia D, Cohn DL, Einstein MH, Mitsuyasu RT, Palefsky JM. Safety and immunogenicity of the quadrivalent human papillomaverius vaccine in HIV-1-infected men. J Infect Dis 2010 202:1246-53. Reviews and Book Chapters: Cohn DL, Judson FN. Genitourinary tuberculosis in men. In: Keith LG, Berger GS, Edelman DA, eds. Infections in reproductive health; Vol. 2: Uncommon infections and special topics. Lancaster: MTP Press Ltd, 1985:27-34. Kirkpatrick CH, Davis KC, Horsburgh Jr CR, Rickmann PE, Cohn DL, Penley KA, Judson FN, Dobozin BS. Immunologic functions and the pathogenesis of the acquired immune deficiency syndrome (AIDS). In: Furmanski P, Hager, Rich MA, eds. RNA tumor viruses, oncogenes, human cancer, and AIDS: on the frontiers of understanding. Boston: Martinus Nijhoff, 1985:254-66. Rumack J. AIDS. In: Honigman B(ed): Emergindex Information System. AIDS Clinical Review Cohn DL (section ed). Micromedex, Inc., 1974-1986. Cohn DL. Bacterial pneumonia in the HIV-infected patient. In: Wallace RJ, ed. Lower respiratory tract infections. Infect Dis Clin North Am 1991;5:485-507. Blum RN, Cohn DL. Epidemiology of human immunodeficiency virus infection and immunopathogenesis predisposing to fungal diseases. In: Sarosi G, Davies S, eds. Fungal diseases of the lung. New York: Raven Press, 1993:229-35. Cohn DL, Horsburgh CR. Treatment and prophylaxis of disseminated Mycobacterium avium complex infection in AIDS. In: Gordin FM, ed, Opportunistic complications of HIV 1993;2:6-12. Cohn DL. Treatment and prevention of tuberculosis in HIV-infected persons. In: Glatt AE, ed. Management of infection in HIV disease. Infect Dis Clin North Am 1994;8:399-412. Burman WJ, Cohn DL. Clinical disease in human immunodeficiency virus-infected persons. In: Korvick JA, Benson CA, eds. Mycobacterium avium complex infection: progress in research and treatment. New York: Marcel Dekker, 1995:79-108. Cohn DL. Treatment and prevention of mycobacterial diseases in HIV infection. In: Grassi GG. New perspectives on antimycobacterial drugs 1995;16-19. Cohn DL. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection: a review of recent studies in patients with AIDS. In: Pechere JC, New prevention strategies for Mycobacterium avium complex. Drugs 1997;54(suppl 2):8-15. Hammer JH, Cohn DL. Tuberculosis: the white plague revisited. In: Gates RH. Infectious disease secrets. Philadelphia: Hanley & Belfus, Inc, 1998;129-36. O'Brien RJ, Cohn DL. Nontuberculous mycobacterial disease. In: Evans AS, Brachman P. Bacterial infections of humans: epidemiology and control. 3nd edition, New York: Plenum Publishing Corporation, 1998;805-21. Cohn DL, El-Sadr WM. Treatment of latent tuberculosis infection. In: Reichman LB, Hershfield ES. Tuberculosis: a comprehensive international approach. 2nd edition, New York: Marcel Dekker, Inc. 2000;471-502. Thrun MW, Cohn DL. Tuberculosis: the white plague revisited. In: Gates RH. Infectious disease secrets. Philadelphia: Hanley & Belfus, Inc, 2nd edition, 2003;164-72. Cohn DL. Treatment of latent tuberculosis infection. In: Glassroth J, ed. Tuberculosis. Seminars in Respiratory Infections 2003;18:249-62. Cohn DL, El-Sadr WM. Treatment of latent tuberculosis infection. In: Raviglione MC. Reichman and Hershfield's Tuberculosis: a comprehensive international approach. 3rd edition, New York: Informa Healthcare USA, Inc. 2006;265-305. Cohn DL. Tuberculosis screening and assessment. In: Hardy DW, ed. AAHIVM Fundamentals of HIV Medicine for the HIV Specialist, American Academy of HIV Medicine, 2012 edition;187-191 Gray JM, Cohn DL. Tuberculosis and HIV coinfection. In: Daley C, ed. Mycobacterial Infections. Seminars in Respiratory and Critical Care Medicine 2013;34: 32-43. Monographs: Cohn DL, ed. Pulmonary disease in the immunocompromised host. Seminars in Respiratory Medicine 1989;10:1-100. Pablos-Mendez A, Laszlo A, Bustreo F, Binkin N, Cohn DL, Lambregts-van Weezebeek CSB, Kim SJ, Chaulet P, Nunn P, Raviglione MC. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance, 1994-1997. Geneva: World Health Organization, WHO/TB/97.229, 1997:1-227. Editorials and Commentaries: Cohn DL, Rush JB. Minimizing AIDS danger puts millions at risk. Rocky Mountain News August 1992; 26:47. Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis: we can't afford not to try it. N Engl J Med 1993; 328:576-8. Sudre P, Cohn DL. M tuberculosis drug resistance: a call for action. Int J Tuberc Lung Dis 1998;2:609-11. O'Brien RJ, Cohn DL. Family practice and the elimination of tuberculosis. Am Fam Physician 2000;61:2629-30,32. Cohn DL. Viewpoints. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control. Clin Infect Dis 2000;31:120-4. O'Brien RJ, Cohn DL. Eliminating tuberculosis in the U.S.: next steps. Infectious Disease News 2000;13:6. Cohn DL. The effect of BCG vaccination on tuberculin skin testing: does it matter? Am J Respir Crit Care Med 2001;164:915-6. Cohn DL. Subclinical tuberculosis in HIV-infected patients: another challenge for the diagnosis of tuberculosis in high-burden countries? Clin Infect Dis 2005;40:1508-10. Cohn DL. Expert Opinion Interview. Influenza H1N1 outbreak. PulmonaryReviews.com. May 2009. Cohn DL. Commentary. Regulatory oversight in infectious diseases research: too much of a good thing? PulmonaryReviews.com. August 2009. Cohn DL. Clinical research and regulatory oversight: a question of balance. Infectious Disease News 2009;22:4-6. Cohn D. Perspective. Study raises concerns about empiric regimen for treatment of HIV-TB coinfection. InfectiousDiseaseNews.com. April 2010. Cohn D. Perspective. Rapid MDR-TB test shown to be effective in resource-limited settings. InfectiousDiseaseNews.com. May 2011. Cohn D, Thrun M. The battle against AIDS is not over. Denver Post; June 12, 2011. Cohn D. Perspective. Studies confirm serological testing inadvisable for TB detection. Infectious Disease News 2011 24:38-9. Cohn D. Perspective. WHO: Funding needed to support global TB decline. Infectious Disease News 2011;24:13. Cohn D. Perspective. Diabetes associated with more TB symptoms, adverse effects. Infectious Disease News Haelio.com/ID April 3, 2012. Cohn D. Commentary. International TB standards provide a valuable springboard for European and US docs. Pulmonary Reviews Blog  HYPERLINK "http://www.pulmonaryreviews.com/blog" www.pulmonaryreviews.com/blog May 12, 2012. Cohn D. Is the world prepared for H5N1 mutations? Pulmonary Reviews Blog  HYPERLINK "http://www.pulmonaryreviews.com/blog" www.pulmonaryreviews.com/blog Commentary:  HYPERLINK "http://ow.ly/bqwHd" http://ow.ly/bqwHd Audiocast:  HYPERLINK "http://t.co/01XuVeL6" \o "http://ow.ly/bqwMN" \t "_blank" http://ow.ly/bqwMN June 6, 2012. Young B, Cohn D. July is national HIV awareness month: Stigma remains a barrier to HIV/AIDS treatment despite significant medical advances. Health Policy Solutions  HYPERLINK "http://www.healthpolicysolutions.org" http://www.healthpolicysolutions.org July 12, 2012. Cohn D. Perspective. FDA recommends accelerated approval of bedaquiline for MDR-TB. Infectious Disease News 2012;25:1,4. Cohn D. Perspective. Once-weekly treatment effective as daily treatment in TB continuation phase. Infectious Disease News, April 2013. Cohn D. Perspective. Ebola in U.S. triggers travel screening, advanced protocols for HCWs. Infectious Disease News 2014;27:1,6,7. Cohn D. Perspective. Ebola 1 year later: hard lessons learned. Experts discuss preparedness for next emerging disease outbreak. Infectious Disease News 2015;28:1,11- 12. Cohn D. Opinion. From Dachau to Sierra Leone: will we ever learn? Health News Colorado, June 2015. Cohn D. Perspective. Spread of HIV via online hookup services raises health concerns. Infectious Disease News 2015;28:1,6. Cohn D. Perspective. Toddler with XDR-TB treated into remission. Infectious Disease News 2015;28:65. Cohn D. Perspective. Urine-based TB test lowers mortality. Infectious Disease News, March 2016. Cohn D. At Issue. Foreign aid programs effective, should be better funded. Infectious Disease News 2016;29:13. Cohn D, Starke J, Schruafnagel D. Commentary. The new face of an old disease: TB over 3 decades. Infectious Disease News 2017:30:1,16. Cohn D. Perspective. WHO: Ending TB will take greater political commitment. Infectious Disease News 2017;30:45. Cohn DL. Editorial. Xpert MTB/RIF Ultra: another advance in TB diagnostics. Infectious Disease News 2018:31:16-7. Cohn DL. Perspective. 1 month of TB prophylaxis as effective as 9 months. Infectious Disease News, March 2018. Cohn DL. Perspective. TB vaccines ineffective against initial infection. Infectious Disease News, 2018;31:36. Cohn DL. Perspective. Novel point-of-care TB test for patients with HIV superior to current test. Infectious Disease News, June 2019. Cohn DL. Perspective. Globally, 3 in every 1,000 people carry latent MDR-TB. Infectious Disease News, 2019;32(8):38. Letters to the Editor: Cohn DL, Penley KA, Judson FN, Kirkpatrick CH, Horsburgh Jr CR, Davis KC. The acquired immunodeficiency syndrome and a trimethoprim-sulfamethoxazole adverse reaction. Ann Intern Med 1984;100:311. Cohn DL, Judson FN. Absence of Kaposi's sarcoma in hemophiliacs with the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:401. Horsburgh CR Jr, Cohn DL. Mycobacterium avium complex and the acquired immunodeficiency syndrome. Ann Intern Med 1986;105:968-9. O'Brien RF, Cohn DL. Serum angiotensin converting enzyme in AIDS. Chest 1990;97:1021-2. Cohn DL, Miller LA, Yamaguchi KJ, Douglas JM. Denver's increase in HIV counseling after Magic Johnson's HIV disclosure. Am J Public Health 1992;82:1692. Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis: We cant afford not to try it. N Engl J Med 1993;329:135-6. Lifson AR, Cohn DL. Use of BCG vaccination. Lancet 2000;356:1609-10. Cohn DL, OBrien RJ. Treatment of LTBI: selling point or semantic blunder? Am J Respir Crit Care Med 2002;165:1338. Castro KG, Jereb JA, Koppaka VR, Cohn DL. Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infection. Chest 2003;123:967. American Thoracic Society Statements and Workshop Reports: Cohn DL, Stover DE, O'Brien RF, Shelhamer JH, Raffin TA, Hopewell PC. Pulmonary complications of AIDS: advances in diagnosis and treatment. Am Rev Respir Dis 1988;138:1051-2. American Thoracic Society. Sarosi GA, Ampel N, Cohn DL, Dismukes WE, Galgiani JN, Glassroth JJ, Graybill RJ, Johnson PC, Hopewell PC, Wheat JL. Fungal infection in HIV-infected persons. Am J Respir Crit Care Med 1995;152:816-22. American Thoracic Society. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161(Part 2):S221-47. Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Molan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R, Sterling TR, on behalf of ATS Hepatotoxicity of Antituberculosis Therapy Subcommittee. An official ATS statement: Hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006;174: 935-52. Morris A, Crothers K, Beck JM, Huang L on behalf of the American Thoracic Society Committee on HIV Pulmonary Disease. An Official ATS Workshop Report: Emerging Issues and Current Controversies in HIV-Associated Pulmonary Diseases. Proc Am Thorac Soc 2011;8:17-26 Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Leffler M, Mazurek GH, OBrien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL. Official American Thoracic Society, Infectious Disease Society of America, Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis 2017;64:e1-e33. Executive Summary 2017;64:11-5. Morbidity and Mortality Weekly (MMWR) Reports: Raevsky CA, Cohn DL, Wolf FC, Judson FN. Transfusion-associated human T-lymphotropic virus type III/lymphadenopathy-associated virus infection from a seronegative donor-Colorado. MMWR Morbid Mort Wkly Rep 1986;35:389-91. Freeman A, Cohn D, Corby N, Wood R. Patterns of sexual behavior change among homosexual/bisexual men - selected sites, 1987-1990. MMWR Morbid Mort Wkly Rep 1991;40:792-4. Schomer K, Douglas JM, Cohn DL, et al. Hepatitis A among homosexual men - United States, Canada, and Australia. MMWR Morbid Mort Wkly Rep 1992;41:155-64. Cohn DL, Rietmeijer CAM, Kane MS, Cooper SG, Martindale CJ, Judson FN. Changes in sexual behavior and condom use associated with a risk-reduction program - Denver, 1988-1991. MMWR Morb Mortal Wkly Rep 1992;41:412-5. Guenther-Gray C, Tross S, McAlister A, Freeman A, Cohn D, Corby N, Wood R, Fishbein M. AIDS Community Demonstration Projects: Implementation of volunteer networks for HIV prevention programs-selected sites, 1991-1992. MMWR Morb Mortal Wkly Rep 1992;41:868-76. U.S. Public Health Service task force on prophylaxis and therapy for Mycobacterium avium complex. Recommendations for prophylaxis and therapy against Mycobacterium avium in adults and adolescents infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1993;42(RR-9):14-20. Community level prevention of human immunodeficiency virus infection among high risk populations: the AIDS community demonstration projects. MMWR Morb Mortal Wkly Rep 1996;45(RR-6):1-24. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morb Mortal Wkly Rep 1998;47(RR-20):1-58. American Thoracic Society, Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep 2000;49(RR-6):1-51. Sterling TR, Njie G, Zenner D, Cohn DL, Reves R, Ahmed A, Menzies D, Horsburgh CR, Crane CM, Burgos M, LoBue P, Winston CA, Belknap R. Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep 2020;69(No. RR-1):111. Weekly Epidemiological Record: Anonymous (Cohn DL). Global Programme on Tuberculosis and Global Programme for Vaccines and Immunization. Statement on BCG revaccination for the prevention of tuberculosis. Weekly Epidemiol Rec 1995;70:229-31. World Health Organization Meeting Report: Anonymous (Cohn DL). The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries: report of a WHO review and planning committee. WHO/TB/95.194:1-18. Obituaries: Castro KG, Cohn DL, Burman WJ, Reves RR, Iseman MD. Obituary: John A. Sbarbaro, 19362011. Int J Tuberc Lung Dis 2011:15:1562. Cohn DL, El Sadr WM, Abrams DI, Neaton JD, Benator DA, Vernon AA. In Memoriam, Fred Gordin, MD, 1951-2018, Clin Infect Dis 2018:67:153. Book Reviews: Belknap RW, Cohn DL. Tuberculosis, 2nd Edition. Rom WN, Garay SM, eds. Philadelphia: Lippincott Williams & Wilkins, 2004. Clin Infect Dis 2004;38:1509-10. Educational Newsletters: Cohn DL. AIDS patient with leukoencephalopathy of unknown etiology. Case and Consensus 1989;19 (January)1-4. Cohn DL. AIDS patient with unusual upper-lobe Pneumocystis carinii pneumonia: problems with drug toxicity. Case and Concensus 1989;2 (April):1-2. Cohn DL. AIDS patient with extrapulmonary tuberculosis. Case and Concensus 1989;2(April):3-4. Cohn DL. Patient with denial of HIV exposure. Case and Concensus 1990;3(September): 3-4. Cohn DL. Mycobacterium avium complex disease in AIDS. Resolute 1994; (May):4-5. Cohn DL. Antiretroviral Rounds. AIDS Clinical Care 1999;11:38,43. Cohn DL. Fluoroquinolones for Shortening Treatment of Tuberculosis: Promises, but not Reality. NTM-TB Insights, National Jewish Health, November 2015. Abstracts and Presentations: Bundtzen RW, Cohn DL, Craig WA. Persistent suppression of growth of gram-negative bacilli after brief exposure to antimicrobials. Clin Res 1979;27:696A. Cohn DL, Reimer LG, Reller LB. Comparative in-vitro activity of MK0787 against 500 blood culture isolates. 20th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, 1980. Reller LB, Anders BJ, Cohn DL, Judson FN. Controlled clinical trial of praziquantel for the treatment of clonorchiasis and opisthorchiasis. American Society of Tropical Medicine and Hygiene. Cleveland, OH, November 1982. Cohn DL, Catlin BJ, Sbarbaro JA, Judson FN, Iseman MD. Evaluation of a four drug, six month directly administered regimen for treatment of tuberculosis. Am Rev RespirDis 1983 (supp);127:192. Cohn DL, Miller KG, Peppler MS, Ehret JM, Judson FN. Comparison of two oral ampicillin regimens for treatment of anorectal and pharyngeal gonococcal infections in homosexual men. International Society for STD Research. Seattle, WA, August 1983. Cohn DL, Reller LB, Paisley JW, Ciesielski CA, Wood J, Penley KA, Coe CA, Mason SR. Controlled clinical trial of norfloxacin for fecal leukocyte-positive diarrhea: background and preliminary results. In: Dierich MP, Ronald A, Shah PM, eds. Proceedings of 13th International Congress of Chemotherapy. 1983;38:41-45. Horsburgh CR, Davis KC, Penley KA, Cohn DL, Judson FN, Kirkpatrick CR. Immune defects in patients at risk for AIDS. J Allergy Clin Immunol 1984;73:169. O'Brien RF, Cohn DL, Lepoff R, Garay SM. Serum angiotension converting enzyme (ACE) activity in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1984 (supp);129:A197. Kirkpatrick CH, Davis KC, Horsburgh CR, Rickmann PE, Cohn DL, Penley KA, Dobozin BS. Pathogenesis of the acquired immune deficiency syndrome. International Conference on RNA Tumor Viruses in Human Cancer. Denver, CO, June 1984. Cohn DL. Chemotherapy of tuberculosis: the Denver experience. National TB Conference. Atlanta, GA, September 1984. Cohn DL, O'Brien RF, Arnall MF. Pleuropulmonary Kaposi's sarcoma in AIDS: clinical, radiographic, and pathologic manifestations. Am Rev Respir Dis 1985 (supp);131:A82. Cohn DL, Muldrow ME, Root CJ, Olin JA, Judson FN. AIDS awareness and changes in sexual activity of patients in a metropolitan STD Clinic. 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. Minneapolis, MI, September 1985. Sharma OK, Buschman FL, Borek E, Cohn DL, Penley KA, Judson FN, Dobozin BS, Zunich KM, Kirkpatrick CM. Aberrant urinary excretion of modified nucleosides in patients with various manifestations of infection with HTLV-III/LAV. Proc 3rd International Conference on Human Tumor Markers. Naples, Italy, April 1986. Cohn DL. AIDS and HTLV-III infection in the workplace. American Occupational Health Conference. Denver, CO, May 1986. Cohn DL, Catlin BJ, Sbarbaro JA, Judson FN. Four drug, six month directly administered therapy of tuberculosis in a metropolitan tuberculosis clinic: second report. Am Rev Respir Dis 1986 (supp);133:A205. Rector W, Govindarajan S, Penley K, Horsburgh C, Cohn D, Judson F. Cellular immune function, hepatitis B viral replication, and liver inflammation in patients with chronic hepatitis B and human immunodeficiency virus antibody. Hepatology 1986;6:1224. Cohn DL, Peterson LC, Daskol SL, Few EC, Judson FN. Comparative analysis of admissions and costs for AIDS patients in a public and a private hospital. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, September 1986. Cohn DL, Raevsky CA, Douglas JM, Wolf FC, Cada RL, Judson FN. Experience with voluntary screening for HTLV-III antibody in Denver. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, September 1986. Douglas JM, Neff PT, Cohn DL, Judson FN. Prevalence of HLTV-III antibody in patients attending a clinic for sexually transmitted diseases. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, September 1986. Douglas, JM, Meiklejohn G, Schiffman G, Cohn DL, Judson, FN. Response to pneumococcal and influenza vaccines in gay men with asymptomatic HTLV-III infection and with AIDS. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, September 1986. Perez-Perez G, Blaser MJ, Cohn DL, Reller LB. Humoral response to Campylobacter cellular antigens and enterotoxin in U.S. cases of inflammatory diarrhea. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, September 1986. Bujwit CA, Douglas JM, Cohn DL, Mahr N, Judson FN. Seroprevelance of antibody to HIV in female prostitutes in Denver. International Conference on AIDS in Children, Adolescents, and Heterosexual Adults. Atlanta, GA, February 1987. Cohn DL, Peterson KL, Penley KA, Judson FN. Severe HIV-related morbidity and mortality in cases not meeting the CDC surveillance definition for AIDS. 3rd International Conference on Acquired Immunodeficiency Syndrome. Washington, DC, June 1987. Cohn DL, Davidson AJ, Penley KA, Judson FN. Mortality in AIDS in Colorado: life-table analysis from the AIDS reporting system. 3rd International Conference on AIDS. Washington, DC, June 1987. Cohn DL, Gourley PJ, O'Reilly KR, Judson FN. Community-based demonstration project for AIDS prevention and risk reduction: organization of a comprehensive prevention program in Denver. 3rd International Conference on AIDS. Washington, DC, June 1987. Rietmeijer CAM, Penley KA, Cohn DL, Horsburgh CR, Davidson AJ, Judson FN. Factors influencing the risk of infection with human immunodeficiency virus in a cohort of homosexual men - Denver 1983-1985. 3rd International Conference on AIDS. Washington, DC, June 1987. Raevsky CA, Dillon B, Scott A, Wolf F, Cohn DL. Transfusion-associated transmission of human immunodeficiency virus (HIV) from a seronegative donor - Colorado. 3rd International Conference on AIDS. Washington, DC, June 1987. Perlman DM, Ampel NM, Cohn DL, Paquin ML, Wang WL, Blaser MJ. Persistent Campylobacter jejuni infection in human immunodeficiency virus-infected patients. 4th International Workshop on Campylobacter Infections. Goteberg, Sweden, June 1987. Perez-Perez GI, O'Brien AD, McCardell B, Cohn DL, Reller LB, Blaser MJ. Humoral response to Campylobacter jejuni cellular antigens and toxins in U.S. cases of inflammatory diarrhea. 4th International Workshop on Campylobacter Infections. Goteborg, Sweden, June 1987. Spencer NE, Dillon B, Rios S, Cohn DL. Investigation of 5 HIV-related deaths in an inner-city family. American Public Health Association. New Orleans, LA, October 1987. Raevsky CA, Dillon B, Scott A, Wolf F, Cohn DL. Transfusion-associated transmission of human immunodeficiency virus (HIV) from a seronegative donor - Colorado. American Public Health Association. New Orleans, LA, October 1987. Janoff EN, Douglas JM, Gabriel M, Cohn DL, Judson FN. Effect of human immunodeficiency virus (HIV) infection on the longitudinal, isotype-specific, humoral response to pneumococcal vaccine. 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. New York, NY, October 1987. Cohn DL, Peterson KL, Penley KA, Judson FN. Severe HIV-related morbidity and mortality in cases not meeting the CDC surveillance definition for AIDS. University of Colorado 7th Annual Epidemiological Research Exchange. Denver, CO, October 1987. Davidson AJ, Cohn DL, Penley KA, Judson FN. Mortality in AIDS in Colorado: life-table analysis from the AIDS reporting system. University of Colorado 7th Annual Epidemiological Research Exchange. Denver, CO, October 1987. Polish LB, Cohn DL, Myers AM, O'Brien RF. Pulmonary lymphoma in AIDS. Am Rev Respir Dis 1988(supp);137:357. Cohn DL, Gourley PJ, Bartholow BN, Bujwit CA, O'Reilly KR, Judson FN. Changes in high risk behavior in a longitudinal cohort of gay and bisexual men. 4th International Conference on AIDS. Stockholm, Sweden, June 1988. Cohn DL, Gourley PJ, Cole VJ, Judson FN. Condom usage for anal intercourse in a longitudinal cohort of gay and bisexual men. 4th International Conference on AIDS. Stockholm, Sweden, June 1988. Ralin PL, Cohn DL, Judson FN. Knowledge, attitudes, and beliefs about AIDS in Colorado. 4th International Conference on AIDS. Stockholm, Sweden, June 1988. Judson FN, Wolf FC, Cohn DL. HIV testing and counseling activity in Colorado: Effects of reporting results by name. 4th International Conference on AIDS. Stockholm, Sweden, June 1988. Judson FN, Douglas JM, Cohn DL. HIV seroprevalence in heterosexual men and women: Denver Metro STD Clinic, 1985-1987. 4th International Conference on AIDS. Stockholm, Sweden, June 1988. Janoff EN, Douglas JM, Gabriel M, Davidson AJ, Cohn DL, Judson FN, Blaser MJ. Effects of human immunodeficiency virus-1 (HIV-1) infection on the antibody class-specific response to pneumococcal capsular polysaccharides. 4th International Conference on AIDS. Stockholm, Sweden, June 1988. Polish LB, Valdez SG, Tapy JM, Cohn DL. Tuberculosis screening in immigrants applying for US citizenship. Am Rev Respir Dis 1989(supp);139:184. Cohn D, Bartholow B, O'Reilly K, Judson F. Perceived need for behavioral change: distinguishing between groups at risk of HIV infection in a longitudinal cohort of gay and bisexual men. 5th International Conference on AIDS. Montreal, Canada, June 1989. Feeney F, Brewster T, Davidson A, Koester S, Burke G, Cohn D. Access to IV drug users (IVDU) through combined efforts of a public health department and indigenous outreach workers. 5th International Conference on AIDS. Montreal, Canada, June 1989. Cohn D, Koleis J, Cooper S, Cole V, Judson F. Incidence of HIV infection in gay and bisexual men attending a counseling and testing site or an AIDS prevention program. 5th International Conference on AIDS. Montreal, Canada, June 1989. Cohn D, Douglas J, Koleis J, Feeney F, Judson F. Comparison of prevalence of HIV infection in IV drug users (IVDU) from four different testing and treatment programs. 5th International Conference on AIDS. Montreal, Canada, June 1989. Judson F, Cohn D, Douglas J. Fear of AIDS and incidences of gonorrhea, syphilis and hepatitis B, 1982-88. 5th International Conference on AIDS. Montreal, Canada, June 1989. Judson F, Cohn D, Douglas J. HIV seroprevalence in heterosexual men and women, Denver Metro STD Clinic, 1985-1988. 5th International Conference on AIDS. Montreal, Canada, June 1989. Miller L, Peterson K, Davidson A, Cohn D. Experience with zidovudine in a city hospital AIDS clinic. 5th International Conference on AIDS. Montreal, Canada, June 1989. Miller L, Cohn D. High rates of recurrent Pneumocystis pneumonia and toxicity in AIDS patients taking pyrimethamine-sulfadoxine prophylaxis. 5th International Conference on AIDS. Montreal, Canada, June 1989. Kobayashi J, Heaton R, Thompson L, Norton I, Cohn D. A comparison of neuropsychological testing and mental status exam in AIDS patients. 5th International Conference on AIDS. Montreal, Canada, June 1989. Galavotti C, O'Reilly K, Higgins D, Sheridan J, Cohn D. Behavioral intentions and other factors influencing behavior change in a cohort of gay men: a prospective study. 5th International Conference on AIDS. Montreal, Canada, June 1989. O'Reilly K, Higgins D, Galavotti C, Sheridan J, Wood R, Cohn D. Perceived community norms and risk reduction: behavior change in a cohort of gay men. 5th International Conference on AIDS. Montreal, Canada, June 1989. Bessesen MT, Miller LA, Bartlett SD, Cohn DL, Ellison III RT. Difficulties with Fansider in a comparative trial for secondary prophylaxis of Pneumocystis carinii pneumonia. 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. Houston, TX, September 1989. Miller LA, Cohn DL. Comparative trial of trimethoprim-sulfamethoxozale and dapsone for primary prophylaxis of Pneumocystis carinii pneumonia. 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. Houston TX, September 1989. Polish CB, Larsen SA, Cohn DL, Douglas JM. Prevalence of serologic markers for syphilis in HIV-seropositive and HIV-seronegative homosexual men. 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. Houston, TX, September 1989. Cohn D, Harrison S, Miller L, Andron L, Gourley P, Hannon R, Bakker P, Gates R, McManus M, Andrews J. Efficacy and toxicity of zidovudine (Z) in early AIDS-related complex (ARC). 6th International Conference on AIDS. San Francisco, CA, June 1990. Andron L, Andrews J, Cohn D, McManus M, Gourley P, Hannon R, Stewart R, White J. Zidovudine treatment in early HIV infection: laboratory studies. 6th International Conference on AIDS. San Francisco, CA, June 1990. Bartholow B, Cohn D, Cole V, Judson F, O'Reilly K. From low-risk to high-risk: distinguishing among groups of gay men on the HIV risk relapse continuum. 6th International Conference on AIDS. San Francisco, CA, June 1990. Earl W, Martindale C, Cohn D. Denial: the continuum of coping mechanism styles with regard to HIV infection. 6th International Conference on AIDS. San Francisco, CA, June 1990. Earl W, Martindale C, Cohn D. Distress profile of HIV-infected single parents: comparisons to target counseling interventions. 6th International Conference on AIDS. San Francisco, CA, June 1990. Earl W, Flinders R, Flahive M, Flinders T, Bartholow B, Kobayashi J, Cohn D. Psychosocial adjustment to HIV infection: efficacy of different group interventions in gay and bisexual men. 6th International Conference on AIDS. San Francisco, CA, June 1990. Earl W, Rogers M, Cohn D. Identifying stressors in HIV-related health workers to target successful interventions. 6th International Conference on AIDS. San Francisco, CA, June 1990. Galavotti C, Schnell D, O'Reilly KR, CDC AIDS Demonstration Projects. Impact of four HIV/AIDS preventions programs on psychosocial factors thought to facilitate risk of behavior change. 6th International Conference on AIDS. San Francisco, CA, 1990. O'Reilly KR, Higgins DL, Galavotti C, CDC AIDS Demonstration Projects. Relapse from safer sex among homosexual men: evidence from four cohorts in the AIDS community demonstration projects. 6th International Conference on AIDS. San Francisco, CA, June 1990. Bartholow B, Cohn D, Cole V, O'Reilly K. Contrasting HIV risk behavior, attitudes, and beliefs among exclusively homosexual and behaviorally bisexual men. 7th International Conference in AIDS. Florence, Italy, June 1991. Martindale CJ, Yamaguchi KJ, Cohn DL. Community identification of intravenous drug users to design targeted interventions. 7th International Conference on AIDS. Florence, Italy, June 1991. Davidson AJ, Rietmeijer CA, St. John MA, Paulson AL, Farizo KM, Buehler JW, Cohn DL. Infectious diseases surveillance among HIV-infected patients in a county health care agency - Adult spectrum of disease. 7th International Conference on AIDS. Florence, Italy, June 1991. Rietmeijer CA, Davidson AJ, Cohn DL. Cost of ambulatory care in HIV infection: evaluation of outpatient utilization and charges in a public hospital. 7th International Conference on AIDS. Florence, Italy, June 1991. Cohn D, Rietmeijer C, St. John M, Paulson A, Hagglund B, Davidson A. Impact of the revised CDC classification system of HIV infection. 8th International Conference on AIDS. Amsterdam, The Netherlands, July 1992. Rietmeijer C, Davis T, Martindale C, Kane M, Cole V, Schnell D, Cohn D. Staging sexual behavior change among men who have sex with men but do not gay identify. 8th International Conference on AIDS. Amsterdam, The Netherlands, July 1992. Shlay J, Blackburn D, Cohn D. HIV seroprevalence and risk assessment of a homeless population in Denver. 8th International Conference on AIDS. Amsterdam, The Netherlands, July 1992. Davidson A, Rietmeijer C, Hagglund B, Paulson A, St. John M, Cohn D. Relation of social factors to health care utilization and health status assessment in HIV-infected patients. 8th International Conference on AIDS. Amsterdam, The Netherlands, July 1992. Reves R, Stone-Venohr B, Hildred G, Kane S, Cohn D. Utility of paired blood cultures in the diagnosis of disseminated Mycobacterium avium complex infection. 8th International Conference on AIDS. Amsterdam, The Netherlands, July 1992. Paulson A, Gulati A, Hagglund B, St. John M, Davidson A, Cohn D, Diaz T, Rietmeijer C. Sexual behavior and condom use among patients with HIV infection. 8th International Conference on AIDS. Amsterdam, The Netherlands, July 1992. Janoff FN, O'Brien J, Cohn DL, Douglas JM. Effect of zidovudine on humoral response to pneumococcal vaccine in HIV-infected patients. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Anaheim, CA, October 1992. Huitt GA, Cohn DL. Prevalence and incidence of tuberculous infection during housestaff training in Denver. American Thoracic Society. San Francisco, CA, May 1993. Hoffman R, Cohn D, Hoxworth T, Miller L, Guilfoile A, Hamman R, et al. Comparison of anonymous and confidential HIV test sites: Colorado, 1990-1992. IX International Conference on AIDS. Berlin, Germany, June 1993. Pechere M, Emler S, Wald A, Bessesen M, Cohn D, Bottger EC, et al. Infection with Mycobacterium genavense: clinical features in 44 cases. IX International Conference on AIDS. Berlin, Germany, June 1993. Church T, Horsburgh R, Brejle T, Cohn D, Gibert C, et al. Effects of disseminated Mycobacterium avium complex and its treatment on survival of AIDS patients: an observational study. IX International Conference on AIDS. Berlin, Germany, June 1993. Bertram S, Rietmeijer C, Hagglund B, Cohn D, St. John MA, Davidson A. Health status measures (HSM) in HIV-infected women and men. IX International Conference on AIDS. Berlin, Germany, June 1993. The DATRI 001 Study Group. Clarithromycin (CL) plus rifabutin (RFB) for MAC prophylaxis: tolerability of the combination. 1st National Conference on Human Retroviruses. Washington, D.C., December 1993. The DATRI 001 Study Group. Clarithromycin (CL) plus rifabutin (RFB) for MAC prophylaxis: evidence for a drug interaction. 1st National Conference on Human Retroviruses. Washington, D.C., December 1993. Gordin F, Cohn D, Sullam P, Schoenfelder J, Wynne B, Horsburgh CR, Rifabutin Study Group. The occurrence of Mycobacterium avium complex (MAC) bacteremia in a standardized cohort of AIDS patients. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, October 1993. Gordin F, Matts J, Cohn D, Nelson E, El-Sadr W. The impact of HIV on tuberculosis (TB) drug resistance rates in the United States. American Thoracic Society International Conference. Boston, MA, May 1994. Rietmeijer CA, Kane MS, Simons PZ, Cohn DL. Increased use of bleach and condoms among injecting drug users in Denver: Outcomes of a community-based HIV prevention program. Prevention 94. Atlanta, GA, April 1994. Rietmeijer, CA, Kane MA, Simons PZ, Cohn DL. A community-level HIV prevention program to increase the use of bleach and condoms among injection drug users in Denver. Second Science Symposium on Drug Abuse, Sexual Risk, and AIDS: Prevention Research 1995-2000. Flagstaff, AZ, August 1994. The DATRI 001 Study Group. Co-administration of clarithromycin (CL) alters the concentration-time profile of rifabutin (RFB). 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, Florida, October 1994. Gardner LI, Harrison SH, Blatt SP, Hendrix CW, Wagner F, Chung RC-Y, Harris RW, Cohn DL, Mayers DL. Effect of delayed vs late zidovudine treatment on disease progression in 1003 HIV-infected patients. 2nd National Conference, Human Retroviruses and Related Infections. Washington, D.C., January 1995. Burman W, Rietmeijer C, Reves R, Cohn D. Treatment of disseminated Mycobacterium avium complex with clarithromycin decreases transfusional requirements. 2nd National Conference, Human Retroviruses and Related Infections. Washington, D.C., January 1995. Cohn DL. Treatment and prevention of mycobacterial diseases in HIV infection. First European Congress of Pharmacology. Milan, Italy, June 1995. Rietmeijer CA, Kane MS, Simons PZ, Cohn DL. Increased use of condoms and bleach among injection drug users in Denver: outcome of a community-level HIV prevention project. Prevention 95. New Orleans, April 1995. Horsburgh CR, Gordin F, Schoenfelder J, Sullam P, Cohn D, Wynne B. Clinical presentation of disseminated M. avium complex (MAC) disease: a case-control analysis. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, September 1995. Gordin F, Nelson E, Matts J, Cohn D, El-Sadr W, Terry Beirn Community Program for Clinical Research on AIDS. The impact of human immunodeficiency virus infection on drug-resistant tuberculosis in the United States. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, September 1995. Benson CA, Cohn CL, Williams P, ACTG 196/CPCRA009 Study Team. A Phase III prospective, randomized, double-blind study of the safety and efficacy of clarithromycin vs. rifabutin vs. CDA-RBT for prevention of Mycobacterium avium complex disease in HIV-positive patients with CD4 counts < 100 cells/ul. 3rd Conference on Retroviruses and Opportunistic Infections. Washington, D.C., January 1996. Burman W, Reves R, Rietmeijer C, Stone B, Cohn D. Relapse of disseminated Mycobacterium avium complex disease and emergence of resistance to clarithromycin despite treatment with a multidrug regimen. 3rd Conference on Retroviruses and Opportunistic Infections. Washington D.C., January 1996 Coeshott C, Cook C, Ohnemus C, Burman W, Caraway P, Cohn D, McCall C. Sulfamethoxazole-specific antibodies in patients with AIDS: a prospective study. American Academy of Allergy and Immunology. New Orleans, LA, 1996. Cohn DL, Bustreo F, Raviglione MC. Drug resistance in tuberculosis: review of the worldwide situation and WHO's global surveillance project. American Thoracic Society International Conference. New Orleans, LA, May 1996. Cohn DL, Fisher E, Franchino B, Hodges J, Chesnut J, Child C, Gibert C, El-Sadr W, Hafner R, Ropka M, Heifets L, Clotfelter J, Munroe D, Caldwell R, Canady K, Horsburgh C, Terry Beirn Community Programs for Clinical Research on AIDS. Comparison of two doses of clarithromycin in a randomized trial of four 3-drug regimens for treatment of disseminated Mycobacterium avium complex disease in AIDS: excess mortality associated with high-dose clarithromycin. XI International Conference on AIDS. Vancouver, Canada, July 1996 Cohn DL, Benson CA, Williams P, Nevin T, Korvick J, Hatfner R, Bourland D, Kopek E, Becker S, Hojczyk P, Timmons P, Child C, ACTG/CPCRA. A prospective randomized, double-blind comparative study of the safety and efficacy of clarithryomycin vs rifabutin, vs the combination for the prevention of Mycobacterium avium complex bacteremia and disseminated MAC disease in HIV-infected patients with CD4 counts <100 cells/mm3. XI International Conference on AIDS. Vancouver, Canada, July 1996. El Sadr W, Perlman DC, Matts JP, Nelson E, Cohn D, Telzak E, Chirgwin K, Salomon N, Olibrice M, Hafner R. Outcome of an induction regimen for the treatment of HIV-related tuberculosis: evaluation of the addition of a quinolone. XI International Conference AIDS. Vancouver, Canada, July 1996. Gordin F, Benson CA, Chaisson RE, Cohn DL, Horsburgh CR, Kemper CA, Tapper ML, Woods DL. Educational survey reveals differences in how infectious disease specialists and non-specialists treat HIV-infected patients. XI International Conference on AIDS. Vancouver, Canada, July 1996. Rietmeijer CA, Davidson AJ, Cohn DL. Decreasing costs for HIV-related medical services associated with shorter survival stays in a public health care system. XI International Conference on AIDS. Vancouver, Canada, July 1996. Cohn D, Fisher E, Franchino B, Peng G, Hodges J, Chesnut J, Gibert C, El-Sadr W, Hafner R, Ropka M, Heifets L, Clotfelter J, Munroe D, Caldwell R, Horsburgh R, CPCRA 027 Protocol Team. A prospective, randomized trial of four 3-drug regimens for treatment of disseminated MAC disease in AIDS: excess mortality associated with high-dose clarithromycin. 4th Conference on Retroviruses and Opportunistic Infections. Washington, DC, January 1997. Burman W, Cohn D, Rietmeijer C, Judson F, Sbarbaro J, Reves R. Noncompliance with directly observed therapy for tuberculosis. American Thoracic Society International Conference. San Francisco, CA, May 1997. Reves R, Burman W, Dalton C, Cohn D, Butler J. A cost-effectiveness analysis of directly-observed therapy versus self-administered therapy for treatment of tuberculosis. American Thoracic Society International Conference. San Francisco, CA, May 1997. Reves R, Tapy J, ONeill M, Cohn D, Burman W. Modern-day Tuberculoid Marion. American Thoracic Society International Conference. San Francisco, CA, May 1997. Reves RR, Blackburn DJ, Malakouti M, Cohn DL, Judson FN. Food handlers screening for tuberculosis: an effective tool for implementing preventive therapy among high-risk, foreign-born populations. TB at the Millenium: Debating the Controversies. Vail, CO, October 1997 Yamaguchi KJ, Alire CR, Jones RB, McSpadden JW, Ortega D, Piper P, Fitch JD, Bull SS, Cohn DL. Denver AIDS Prevention: an integrated program for prevention of HIV/AIDS. HIV/AIDS Prevention Information Exchange. Lakewood, CO, December 1997. El-Sadr WM, Perlman D, Matts J, Nelson E, Cohn D, Saloman N, Olibrice M, Telzak E, Jones B, Hafner R. Intermittent short course therapy for treatment of HIV-related pulmonary tuberculosis: a prospective randomized trial in the U.S. American Thoracic Society International Conference. Chicago, IL, April 1998. Cohn DL, Davidson AJ, Burman WJ, Coca VJ, Reves RR, Rietmeijer CA. Decreases in HIV-related morbidity, mortality, and health care utilization related to highly active antiretroviral therapy (HAART). XII World AIDS Conference. Geneva, Switzerland, June 1998. Okwera A, Johnson JL, Nsubuga P, Whalen C, Cohn DL, Mugerwa R, Ellner J. Ethambutol (EMB) in continuation phase of tuberculosis (TB) treatment in HIV-1 infected Ugandan adults. XII World AIDS Conference. Geneva, Switzerland, June 1998. Gordin F, Sullam P, Shafran S, Cohn D, Horsburgh CR. A placebo-controlled trial of rifabutin added to a regimen of clarithromycin and ethambutol in the treatment of M. avium complex (MAC) bacteremia. XII World AIDS Conference. Geneva, Switzerland, June 1998. Fisher E, Brosgart C, Cohn D, Chaloner C, Pulling C, Alston B, Schmetter B, El-Sadr W. Placebo-controlled, multicenter trial of adefovir dipivoxil in patients with HIV disease. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, IL, February 1999. Fisher E, Brosgart C, Cohn D, Chaloner K, Pulling C, Schmetter B, Alston B, El-Sadr W. Safety of adefovir dipivoxil and incidence of proximal renal tubular disorder in a placebo-controlled trial in patients with advanced HIV disease. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, IL, February 1999. Brosgart C, Fisher E, Pulling C, Chaloner K, Cohn D, El-Sadr W, Verheggen R, Schmetter B, Alston B. Prevalence of asymptomatic CMV retinitis in AIDS patients. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, IL, February 1999. Lehman DW, Davidson AJ, Cohn DL. Temporal trends in healthcare seeking behavior among HIV-infected patients: impact of early intervention services. Society of General Internal Medicine 22nd Annual Meeting. San Francisco, CA, April 1999. Rietmeijer CA, Davidson AJ, Cohn DL. Substance abuse and high-risk sexual behaviors among persons with HIV infection accessing medical services in a public health care system. National HIV Prevention Conference. Atlanta, GA, August 1999. Fisher E, Cohn D, Chaloner K, Grant L, Brosgart C, El-Sadr W, Alston B, Schmetter B. Effect of adefovir dipivoxil on hepatitis B viral load in a subset of HIV+ patients from a randomized trial of adefovir in advanced HIV disease. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, September 1999. El-Sadr WM, Eberly LE, Cohn DL. Mortality associated with HIV-related opportunistic diseases prior to and since HAART. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA September 1999. Dworkin M, McCombs S, Adams M, Jones J, Davidson A, Cohn D, McCarthy W, Thompson M, Morse A, Horwitch C, Buskin S. Treatment of tuberculosis in HIV-infected patients: a complicated course of therapy. 7th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, January 2000. Kaplan J, Hanson DL, Karon J, Cohn DL, Thompson MA, Buskin S, Fleming PL, Dworkin MS. Early initiation of combination anti-retroviral therapy: does it affect long-term outcome? XIII International AIDS Conference. Durban, South Africa, July 2000. Flaks R, Burman W, Gourley P, Cohn D, Rietmeijer C, Bull S. HIV transmission risk factors among those in HIV clinical care. National STD Prevention Conference. Milwaukee, WI, December 2000. Flaks R, Burman W, Gourley P, Rietmeijer C, Bull S, Cohn D. Unsafe sex among persons in HIV care is associated with decreased adherence with antiretroviral therapy. 8th Conference on Retroviruses and Opportunistic Infections. Chicago, IL, February 2001. Kaplan J, Hanson D, Karon J, Cohn D, Thompson M, Buskin S, Fleming P, Dworkin M. Late initiation of antiretroviral therapy (at CD4+ lymphocyte count <200 cells/(L) is associated with increased risk of death. 8th Conference on Retroviruses and Opportunistic Infections. Chicago, IL, February 2001. Terra M, Burman W, Breese P, Reves R, Cohn D. Streptomycin vs ethambutol as the 4th drug in highly intermittent, directly-observed tuberculosis treatment. American Thoracic Society International Conference. San Francisco, CA, May 2001. Terra M, Burman W, Breese P, Reves R, Cohn D. Six-month, intermittent, directly observed therapy for isoniazid-resistant tuberculosis. American Thoracic Society International Conference. San Francisco, CA, May 2001. Terra M, Burman W, Breese P, Reves R, Cohn D. Incidence and severity of hepatotoxicity during tuberculosis treatment. American Thoracic Society International Conference. San Francisco, CA, May 2001. Terra M, Burman W, Breese P, Reves R, Cohn D. Lack of toxicity during concomitant directly observed isoniazid and disulfiram. American Thoracic Society International Conference. San Francisco, CA, May 2001. Rietmeijer CA, Flaks RC, Gourley PJ, Cohn DL, Burman WJ. Developing a prevention program for persons living with HIV in an HIV clinical care setting. National HIV Prevention Conference. Atlanta, GA, August 2001. Aisu T, Cohn D, Mubiru F, Ssebbanja P, Sawert H, Adatu-Engwau F, Raviglione M. Feasibility of isoniazid preventive therapy of tuberculosis in HIV-infected persons in Uganda. 1st IAS Conference on HIV Pathogenesis and Treatment. Buenos Aires, Argentina, July 2001. Bonds L, Gaido L, Bielski M, Woods J, Cohn D, Wilson M. Infectious disease detected at autopsy among patients at an urban public hospital: 1996-2001. United States and Canadian Academy of Pathology Annual Meeting. Chicago, IL, February 2002 Cohn DL, Aisu T, Mubiru F, Adatu Engwau F, Raviglione MC. Feasibility of preventive therapy in HIV-infected Ugandans: role of chest x-ray screening in detecting possible tuberculosis. 4th World Congress on Tuberculosis. Washington, DC, June 2002. Cohn DL, Breese PS, Burman WJ, Lopez DL, Barth BL, Rietmeijer CAM, Davidson AJ. Continued benefit from highly active antiretroviral therapy: trends in AIDS-related opportunistic illnesses in a public health care systems, 1990-2000. 14th International AIDS Conference. Barcelona, Spain, July 2002. Peterson KL, Burman WJ, Yun LW, Cohn DL, Davidson AJ. When to start? the effect of adherence on disease progression after the initiation of combination antiretroviral therapy. 14th International AIDS Conference. Barcelona, Spain, July 2002. Rietmeijer CAM, Davidson AJ, Cohn DL. HIV-related health care utilization and charges in a public health care facility: trends in relation to the introduction of highly active antiretroviral therapy. 14th International AIDS Conference. Barcelona, Spain, July 2002. Kaplan JE, Hanson DL, Cohn DL, Karon J, Buskin S, Thompson M, Fleming P, Dworkin MS. When to start HAART? Evidence supporting initiation of therapy at CD4+ lymphocyte count <350 cells/uL. 14th International AIDS Conference. Barcelona, Spain, July 2002. Yun L, Burman WJ, Cohn DL, Cave MD, Reves RR. Persistence of tuberculosis in a low incidence metropolitan area: lack of progress toward TB elimination in Denver, Colorado despite evidence of decreasing transmission. 99th International American Thoracic Society Conference. Seattle, WA, May 2003. Gordin FM, Matts J, OBrien R, Chaisson RE, Cohn D. Rifampin and pyrazinamide is not hepatotoxic in the treatment of latent tuberculosis infection in HIV+ persons. 99th International American Thoracic Society Conference. Seattle, WA, May 2003. Belknap RW, Yun LW, Reves RR, Cohn DL, Burman WJ. Tuberculosis and HIV co-infection in a low incidence area: Denver, 1984-2002. 100th International American Thoracic Society Conference. Orlando, FL, May 2004. Yun L, Ogle J, Cohn DL, Burman W, ONeill M, Reves RR. Barriers to pediatric tuberculosis elimination in a low-incidence area: Denver, Colorado. 100th International American Thoracic Society Conference. Orlando, FL, May 2004. Reves R, Yun L, Belknap R, ONeill M, Yang Z, Cave D, Burman W, Cohn D. Persistent TB in Denver: a decade of genotypic and epidemiologic data in a low-incidence community. 2004 National TB Controllers Workshop. Atlanta, GA, June 2004. Jenkins T, Gardner E, Thrun M, Cohn D, Burman W. Opportunities for earlier diagnosis of HIV infection: a review of patient encounters prior to diagnosis. 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February 2005. El-Sadr W, Neaton J, for the SMART Study Investigators. Episodic CD4-guided use of antiretroviral therapy is inferior to continuous-therapy: results of the SMART study. 13th Conference on Retroviruses and Opportunistic Infections. Denver, CO, February 2006. Cohn D, for the SMART Study Group. Severity and types of clinical events by proximal CD4 cell counts in the SMART Study. 16th International AIDS Conference. Toronto, Canada, August 2006. INVITED LECTURER, MODERATOR, OR PARTICIPANT AT MEETINGS OF INTERNATIONAL, NATIONAL, OR REGIONAL IMPORTANCE: Tuberculosis contact investigation. Sunrise Seminar, American Thoracic Society. Kansas City, MO, May, 1983. Moderator, AIDS presentation/poster session. American Thoracic Society. Miami, FL, May 1984. Pulmonary infections in AIDS. Meet the Professor Seminar. American Thoracic Society. Miami, FL, May 1984. Isoniazid preventive therapy. Compliance in treatment of tuberculosis. Navy Occupational and Environment Health Workshop. Virginia Beach, VA, March 1985. Moderator, AIDS presentation/poster session. American Thoracic Society, Anaheim, CA, May 1985. AIDS: etiology, clinical manifestations, and treatment. Medical Grand Rounds. University of Colorado Health Sciences Center. Denver, CO, May 1985. Pulmonary Complications of AIDS. Colorado Trudeau Society Durrance Conference. Estes Park, CO, September 1986. AIDS - 1987. Visiting Professor, Infectious Diseases Division. University of Iowa Hospitals. Iowa City, IA, April 1987. Tuberculosis contact investigation. Sunrise Seminar, American Thoracic Society, New Orleans, LA, May 1987. Treatment of M. avium complex disease in AIDS. American Thoracic Society. New Orleans, LA, May 1987. Mycobacterioses: old diseases, new directions. Medical Grand Rounds. University of Wisconsin Hospitals, Madison, WI, September 1987. AIDS Update. American College of Physicians Colorado Scientific Meeting. Colorado Springs, CO, January 1987. Clinical Manifestations and Treatment of AIDS. 2nd Annual Rocky Mountain Regional Conference on AIDS. Denver, CO, January 1987. AIDS: Epidemiology, Natural History, and Clinical Manifestations. Wyoming Medical Society Annual Meeting. Cody, WY, January 1987. AIDS Update. Indian Public Health Service. Telluride, CO, February 1987. HIV Infection: Virology, Natural History, and Epidemiology. American Cancer Society AIDS Conference. Colorado Springs, CO, May 1987. Clinical Manifestations and Treatment of AIDS. NIAID AIDS Conference for Nurses and Social Workers. Denver, CO, October 1987. AIDS and HIV Infection: Advances in Treatment and Prevention. Medical Grand Rounds University of Colorado Health Sciences Center. Denver, CO, January 1988. Clinical Manifestations and Treatment of AIDS. AIDS: The Spokane Community Responds. Spokane, WA, January 1988. Mycobacterioses in HIV Infection. Medical Grand Rounds. University of Nebraska Medical Center. Omaha, NE, April 1988. Moderator, Pulmonary Complications of HIV Infection: Advances in Diagnosis and Therapy. American Thoracic Society. Las Vegas, NV, May 1988. Treatment of HIV: Innovations in Antiviral and Immunotherapy. American Thoracic Society. Las Vegas, NV, May 1988. Tuberculosis and HIV Infection: The Coexistence of Two Epidemics. American Thoracic Society. Las Vegas, NV, May 1988. Moderator, The TB/AIDS Dilemma in Private Practice and Public Health Programs. American Thoracic Society. Las Vegas, NV, May 1988. AIDS and HIV Infection: Disease Manifestations, Costs of Care and Cost-effective Treatment Programs. National Conference of State Legislatures. Reno, NV, July 1988. Tuberculosis and AIDS: Clinical Presentations, Treatment, and Prevention. American College of Chest Physicians. Anaheim, CA, October, 1988. AIDS: What's Happening in Denver. AIDS Conference for High School Journalists. University of Denver. Denver, CO, October 1988. AIDS and HIV Infection: 1988. Obstectrics/Gynecology Grand Rounds. University of Colorado Health Sciences Center. Denver, CO, November 1988. AIDS and Associated Blood Borne Diseases - Up to the Present. Colorado Blood Banking Conference. Breckenridge, CO, January 1989. Clinical Manifestations of AIDS. 4th Annual Rocky Mountain Regional Conference on AIDS. Denver, CO, January 1989. AIDS Update - 1989. Medical Grand Rounds, St. Joseph Hospital. Denver, CO, March 1989. The Denver Community-Based AIDS Prevention Demonstration Project. Preventive Medicine Grand Rounds. University of Colorado Health Sciences Center. Denver, CO, May 1989. Moderator, Prevention, Diagnosis, and Management of Pneumocystis carinii Pneumonia in AIDS. American Thoracic Society. Cincinnati, OH, May 1989. Fever of Unknown Origin. University of Colorado Internal Medicine Update. Estes Park, CO, July 1989. AIDS Update. Intermountain States Seminar. Jackson Hole, WY, September 1989. Advances in AIDS Research. Colorado AIDS Project Public Forum. Denver, CO, September 1989. AIDS: Clinical Manifestations and Advances in Treatment. Rocky Mountain Poison Center Practical Therapeutics Conference. Denver, CO, October 1989. AIDS and HIV Infection: Advances in Treatment and Prevention. Surgery Grand Rounds. University of Colorado Health Sciences Center. Denver, CO, October 1989. AIDS: Epidemiology, Clinical Manifestations and Treatment. Legal Center's Program on AIDS, University of Denver Law School. Denver, CO, October 1989. Briefing on AIDS and HIV Infection for Association of Broadcasters. Denver, CO, January 1990. Co-Chair, New Concepts Regarding the Use of Zidovudine (AZT). 6th International Conference on AIDS. San Francisco, CA, June 1990. HIV Update - Diagnosis and Treatment, University of Colorado Internal Medicine Conference. Estes Park, CO, July 1990. Epidemiology of HIV Infection and Risk to Health Care Workers. Colorado Association for Infection Control. Denver, CO, August 1990. Experimental AIDS Therapies. Rocky Mountain Drug Consultation Center. 11th Annual Conference on Practical Therapeutics. Denver, CO, October 1990. Advances in Diagnosis and Treatment of Opportunistic Diseases Associated with HIV Infection. New Mexico AIDS Education and Training Center 2nd Annual Conference on HIV Infection. Albuquerque, NM, November 1990. HIV Disease Update. Northern Colorado Medical Center Infectious Diseases Update. Greeley, CO, November 1990. Treatment of Opportunistic Infections in AIDS. 6th Annual Rocky Mountain Regional Conference on AIDS. Denver, CO, January 1991. Clinical Manifestations of HIV Infection. 6th Annual Rocky Mountain Regional Conference on AIDS. Denver, CO, January 1991. AIDS and HIV Infection. Hospital Grand Rounds, Valley View Hospital. Glenwood Springs, CO, March 1991. Mycobacterioses and HIV Infection. Infectious Diseases Grand Rounds, Henry Ford Hospital. Detroit, MI, April 1991. Viral Infections in the Immunocompromised Host. American Thoracic Society. Anaheim, CA, May 1991. AIDS and the Health Care Worker. Medical Grand Rounds, St. Anthony's Hospital. Denver, CO, July 1991. Blood, Sweat and Tears: Infection Control in the Emergency Room. Colorado Trauma Institute. Breckenridge, CO, August, 1991. Parasitic Diseases of Importance in United States and Developing Countries. Internal Medicine Board Review Course. Denver, CO, August 1991. Drug Therapy of Tuberculosis. Rocky Mountain Drug Consultation Center. 12th Annual Conference on Practical Therapeutics. Denver, CO, October 1991. Advances in Treatment of AIDS and HIV Infection. Owen Health Care Services Symposium. Houston, TX, October 1991. Tuberculosis and HIV Infection. Infectious Diseases Grand Rounds, Duke Medical Center. Durham, NC, January 1992. Diagnosis and Treatment of Tuberculosis. Pueblo County Health Department. Pueblo, CO, February 1992. AIDS Update. Pueblo County Medical Society. Pueblo, CO, February 1992. AIDS Clinical Update. 7th Annual Rocky Mountain Regional Conference on HIV Disease. Denver, CO, February 1992. Mycobacterioses in HIV Infection. Medical Grand Rounds, University of Colorado Health Sciences Center. Denver, CO, March 1992. Epidemiology and Transmission of Tuberculosis. Tuberculosis and HIV Infection. Mycobacterium avium and HIV Infection. Screening for Tuberculosis and Contact Investigation. National Jewish Center Course on Clinical Management and Control of Tuberculosis. New York Academy of Medicine. New York City, NY, March 1992. The Face of HIV Infection in the 90's. HIV Infection and Health Care Workers. Colorado Gynecological Obstetrical Society President's Symposia. Denver, CO, March 1992. Tuberculosis in High-Risk Populations. Mycobacteria and AIDS. Tuberkulose Symposium. Institute for Medicine and Microbiology, University of Zurich. Zurich, Switzerland, May 1992. Tuberculosis: Old Disease, New Problems. Update on AIDS. 38th Annual Family Practice Review. Estes Park, CO, June 1992. Outreach to the Homeless and Displaced Populations - Tuberculosis Treatment. California Medical Association. San Francisco, CA, August 1992. Tuberculosis in the 1990s. Medical Grand Rounds. William Beaumont Hospital. Royal Oak, MI, September 1992. Prophylaxis and Treatment of Patients with MDR-TB. 32nd Interscience Conference in Antimicrobial Agents and Chemotherapy. Anaheim, CA, October 1992. Spectrum of M. avium Disease in AIDS Patients. Frontiers in Mycobacteriology: M. avium, the Modern Epidemic. Vail, CO, October 1992. Mycobacterioses in HIV infection. East Bay AIDS Center. Berkley, CA, December 1992. AIDS Clinical Update. Prophylaxis of Opportunistic Infections. 8th Annual Rocky Mountain Regional Conference on AIDS. Denver, CO, February 1993. Treatment of Tuberculosis in the 1990's. Midwest Infectious Disease Conference - University of Iowa. Iowa City, IA, March 1993. AIDS Clinical Update. University of South Dakota School of Medicine TeleConference, April 1993. Tuberculosis in the 1990s. Medical Grand Rounds, Good Samaritan and Emanuel Hospitals. Portland, OR, April 1993. Tuberculosis: Past and Future. Medical Grand Rounds, Washington V.A. Medical Center, Washington, D.C, May 1993. Treatment of Tuberculosis in HIV Infection. American Society for Microbiology. Atlanta, GA, May 1993. Infectious Disease in the Workplace: Tuberculosis and AIDS. Federal Public Defender Administration and Management Workshop. Denver, CO, May 1993. Treatment and Prevention of M. avium Infection in AIDS. Pan American Congress of Infectious Diseases. Vina Del Mar, Chile, May 1993. The Challenge of Multidrug-resistant Tuberculosis. International AIDS Therapy Group Symposium. IX International Conference on AIDS. Berlin, Germany, June 1993. Tuberculosis in the HIV Era: Working Together to Protect the Public's Health. Wisconsin AIDS/HIV Annual Conference. Madison, WI, September 1993. Current Concepts in the Treatment of Tuberculosis. Infectious Diseases. Current Concepts and Emergency Therapies in Emerging Care. Dearborn, MI, September 1993. Tuberculosis and HIV infection, 6th National AIDS Update Conference, San Francisco, CA, October 1993. Directly Observed Therapy for Tuberculosis - the Denver Experience. 17th AIDS Clinical Trials Group Meeting. Washington, D.C., December 1993. Opportunistic Infections in AIDS. Medical Grand Rounds, University of California at San Diego. San Diego, CA, January 1994. Dermatological Complications of AIDS. Colorado Dermatological Society. Denver, CO, March 1994. AIDS Update. 8th Annual Genitourinary Cancer Update, University of Colorado Health Sciences Center. Denver, CO, March 1994. Multidrug-Resistant Tuberculosis in the Era of AIDS. Albert C. Guggenheim Lecture. Rose Medical Center. Denver, CO, April 1994. Non-Tuberculous Mycobacteria and AIDS. American Thoracic Society International Conference. Boston, MA, May 1994. Treatment of Multi-resistant Mycobacterial Infections. 3rd International Conference of the Hospital Infection Control Society. London, United Kingdom, September 1994. Drug Resistance in Tuberculosis: Global situation and WHO's Approach to Surveillance. WHO Scientific Working Group on Monitoring and Management of Bacterial Resistance to Antimicrobial Agents. World Health Organization, Geneva, Switzerland, November 1994. Tuberculosis and HIV Infection. Infectious Diseases Grand Rounds, Hospital Cantonal, University of Geneva, Geneva, Switzerland, December 1994. Worldwide Overview of Mycobacterial Diseases. Prevention of Mycobacterial Infections in HIV-infected Patients. 2nd National Conference on Human Retroviruses and Related Infections. Washington, D.C., January 1995. Tuberculosis and HIV Infection. Treatment of Multidrug-Resistant Tuberculosis. Epidemiology, Treatment and Prevention of Mycobacterium avium complex infections. Symposium on Chronic Pulmonary Infection. Pokeno, New Zealand, March 1995. Co-Chair, New perspectives on Antimycobacterial Drugs. First European Congress of Pharmacology, University of Milan, Italy, June 1995. Treatment and Prevention of Mycobacterial Diseases in HIV Infection. University of Zurich, Zurich, Switzerland, June 1995. Update on Prophylaxis and Treatment of Opportunistic Infections. 11th Annual Rocky Mountain Regional Conference on HIV Disease. Denver, CO, February 1996. Tuberculosis in the World: Back to the Future. Medical Grand Rounds. University of Colorado Health Sciences Center. Denver, CO, February 1996. Prevention Strategies for MAC: A Review of Recent Studies. 4th International Conference in the Prevention of Infection. Nice, France, May 1996 Global Patterns of Resistance of M. tuberculosis. American Thoracic Society International Conference. New Orleans, LA, May 1996. NIH Study of Levofloxacin in HIV-infected TB Patients. Update on Preventive Therapy Studies. Working Group on Clinical Trials in Tuberculosis Treatment, Annual Meeting of the International Union Against Tuberculosis and Lung Disease. Paris, France, October 1996. Preventive Therapy for the HIV-infected Patient. Aster Challenge Lecture. Paris, France, October 1996. TB in the Developing World: Implications for Health Care Workers. 32nd Annual Conference on Occupational Medicine - The Global Community: Emerging Issues. Denver, CO, January 1997. Drug Resistance: When Programs Fail. 2nd Annual Meeting. North American Region International Union Against Tuberculosis and Lung Disease, Chicago, IL, March 1997. Tuberculosis and AIDS: Emergence of Two Epidemics. Rocky Mountain Branch-American Society for Microbiology, Denver, CO, April 1997. AIDS and the Lungs. Clinical Presentation and Diagnosis of Opportunistic Infections. American Society for Microbiology, 97th General Meeting, Miami, FL, May 1997. Tuberculosis in the World: Back to the Future. Medical Grand Rounds. University of Wisconsin Hospitals, Madison, WI, June 1997. TB Preventive Therapy in HIV-infected Persons. CDC Conference on HIV-Associated Tuberculosis. Atlanta, GA, September 1997. Preventive Therapy for Tuberculosis in HIV-Infected Persons. Princess Marina Hospital, Gaberone, Botswana, November 1997 Tuberculosis: A Worldwide Perspective. Tuberculosis Update on Diagnosis and Treatment. Infectious Disease Medical Conference, Wyoming Medical Center. Casper, WY, April 1998. The Challenge of Treatment of Multi-Drug Resistant Tuberculosis in Middle and Low Income Countries. 8th International Congress on Infectious Diseases. Boston, MA, May 1998. Treatment of Tuberculosis in Patients with Liver Disease. Tuberculosis Workshop. 36th Annual Meeting of the Infectious Diseases Society of America. Denver CO, November 1998. HIV/AIDS in Africa. Association of AIDS Nursing Care. Denver CO, January 1999. The Case for Conservative Management of Early HIV Infection. Massachusetts Infectious Diseases Society, Boston, MA, January 1999. Preventive Therapy for Tuberculosis. Medical Grand Rounds, Harlem Hospital Medical Center, New York, NY, January 1999. The Evolving Clinical Presentation of HIV/AIDS. 14th Annual Rocky Mountain Regional Conference on HIV Disease. Denver, CO, February 1999. Treatment of Latent Tuberculosis Infection: Where Are We in 1999? Tuberculosis in 1999: New Strategies for Treatment and Prevention, Rochester, NY, March 1999. Treatment of Latent Tuberculosis Infection. Tuberculosis Workshop. 37th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, November 1999. Disseminated Tuberculosis in AIDS Resulting in Septic Shock. Tuberculosis Workshop. 37th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, November 1999. Clinical Year in Review: Mycobacterial Disease. American Thoracic Society 2000 International Conference, Toronto, Canada, May 2000. New Recommendations for the Treatment of LTBI: Are They Evidence Based? Advances in the Treatment of Latent TB Infection (LTBI): From Theory to Practice. American Thoracic Society 2000 International Conference, Toronto, Canada, May 2000. Advances in the Treatment of Latent TB Infection. Symposium. Advances in the Treatment of Tuberculosis. American Society for Microbiology 100th Annual Meeting, Los Angeles, CA, May 2000. Paradoxical Reactions in Patients with Mycobacterial Infections on HAART. Tuberculosis Workshop. 38th Annual Meeting of the Infectious Diseases Society of America. New Orleans, LA, September 2000. New Treatment Guidelines for Latent TB Infection. 6th Annual Four Corners TB Conference. Durango, CO, October 2000. New Recommendations for Treatment of Latent TB Infection. Medical Grand Rounds. Henry Ford Hospital, Detroit, MI, February 2001. Treatment of Latent TB Infection: Obstacles and Opportunities. 6th Annual Conference of International Union Against Tuberculosis and Lung Disease North American Region. Chicago, IL, March 2001. Defining DOT: What Factors Need to be Considered in Creating DOT Programs? Examining the Risks and Benefits of Directly Observed Therapy for Treatment of HIV Disease. Forum for Collaborative HIV Research. Washington, DC, April 2001. Treatment of Latent Tuberculosis Infection: New Recommendations. Medical Grand Rounds; University of Massachusetts Medical School. Worcester, MA, May 2001. Who Are We and Who Are Our Patients? HIV/AIDS Care in Safety Net Systems: Current and Future Challenges. Santa Fe, NM, June 2001. The HIV/AIDS Pandemic: Past, Present, and Future. Medical Grand Rounds. University of Colorado Health Sciences Center. Denver, CO, September 2001. Issues in Prevention: Infection Control and Latent Tuberculosis Infection. Tuberculosis Workshop. 39th Annual Meeting of the Infectious Disease Society of America. San Francisco, CA, October 2001. Update on HIV Treatment Guidelines. Tuberculosis and HIV Infection: the Merging of Two Epidemics. Tenth Annual HIV/STD Conference, Illinois Department of Public Health. Springfield, IL, November 2001. Treatment of Latent Tuberculosis Infection. 26th Annual Iowa Infection Control Seminar. Des Moines, IA, May 2002. Discussion Facilitator, Treatment of Tuberculosis. American Thoracic Society International Conference, Atlanta, GA, May 2002. Rapporteur. HIV-Associated Tuberculosis. Should TB Infrastructure be Used to Deliver AIDS Therapy in High Burden Countries? 4th World Congress on Tuberculosis. Washington, DC, June 2002. Bits and Blurbs from Barcelona: Report on the XIV International AIDS Conference. Quarterly HIV Providers Update. Oklahoma City, OK, September 2002. Treatment of Latent Tuberculosis Infection. Infectious Diseases Grand Rounds. University of Oklahoma Medical Center. Oklahoma City, OK, September 2002. International Issues in Tuberculosis. Tuberculosis Workshop. 40th Annual Meeting of the Infectious Diseases Society of America. Chicago, IL, October 2002. AIDS in Africa. Preventive Medicine Grand Rounds. University of Colorado Health Sciences Center. December 2002. Tuberculosis in the World: The Impact of HIV/AIDS. Annual Meeting of Partnership for Access to Clinical Trials, Washington, DC, January 2003. Clinical Care of Adults with HIV: Baseline Clinical Assessment. Antiretroviral Therapy in Adults. MTCT-Plus Training Course. Eldoret, Kenya, January 2003. Antiretroviral Therapy for Patients with TB. 3rd Global TB/HIV Working Group Meeting. Montreux, Switzerland, June 2003. ATS/CDC/IDSA Tuberculosis Treatment Guidelines: Implementation in Public Health Settings. 53rd Annual TB/RD Institute. Black Mountain, NC, July 2003. Tuberculin Skin Testing and Latent Tuberculosis Infection. Diagnosis and Treatment of Active Tuberculosis. MTCT-Plus Training Course. Kisumu and Eldoret, Kenya, February 2004. Treatment of Latent TB Infection: Where Are We Now? Medical Grand Rounds. A.G. Holley State Hospital. Lantana, FL, April 2004. Facilitator. Use of Antiretroviral Therapy in Patients with HIV-Related TB. Expert Consultation on TB/HIV Research Priorities in Resource Limited Settings. World Health Organization, Geneva, Switzerland, February 2005. The Global Tuberculosis and HIV Epidemics. Monash Infectious Diseases Society Meeting. The Alfred Hospital, Melbourne, Australia, June 2005. Tuberculosis and HIV: The Global Epidemic and Challenges in Treatment. Infectious Diseases Grand Rounds. Henry Ford Hospital. Detroit, MI, September 2005. Tuberculosis and HIV: The Global Epidemic and Challenges in Management. Twin Cities AIDS Clinician Meeting, Minneapolis, MN, December 2005. Convenor, Dangerous Liaisons HIV and Associated Epidemics. 13th Conference on Retroviruses and Opportunistic Infections, Denver, CO, February 2006. Rapporteur, HIV and TB in the Context of Universal Access: What is Working and What is Not? WHO TB/HIV Working Group, Toronto, Canada, 2006. Management of Patients with TB and HIV: Challenges in Diagnosis and Treatment. World AIDS Day. CDC Kenya, Nairobi, Kenya, December 2006. Tuberculosis and HIV: Epidemiology and Diagnosis. Treatment of Tuberculosis: Challenges in the HIV-Infected Patient. Treatment of Latent TB Infection: Lessons Learned in Treatment of HIV-Infected Patients. Pulmonary Complications of AIDS. Project HOPE HIV/AIDS Training Course. Wuhan University. Wuhan, Hubei Province, China, March 2007. Tuberculosis and HIV: Global Epidemiology, Diagnosis, and Treatment. Wuhan Provincial Tuberculosis Hospital, Wuhan, Hubei Province, China, March 2007. Chair, The Epidemiology of Tuberculosis: From the Genome to Contact Investigation. American Thoracic Society 2007 International Conference, San Francisco, CA, May 2007. Prevention of TB Transmission in Resource-Limited Settings: A perspective for ICAP Kenya. Nairobi and Kiambu, Kenya, October 2007. HIV/AIDS in Africa and China: Two Ends of the Earth? World AIDS Day. Denver Public Health, Denver, CO, November 2007. Non-Tuberculous Mycobacterial Disease in HIV-infected patients in the Era of Antiretroviral Therapy. Emerging Issues and Current Controversies in HIV-associated Pulmonary Disease. American Thoracic Society International Conference, Toronto, Canada, May 2008. Facilitator, Thematic Poster Session, Tuberculosis: Epidemiology and Behavioral Studies. American Thoracic Society International Conference, Toronto, Canada, May 2008. Tuberculosis and HIV: Global Epidemiology and Diagnosis. Treatment of Tuberculosis: Principles of Therapy and Approach in Resource-Limited Settings. Treatment of HIV in Patients with Tuberculosis: Challenges in Management. Simply Speaking Uganda National HIV/AIDS Update Meeting, Joint Clinical Research Centre. Entebbe, Uganda, September 2008. Prevention of TB Transmission in Resources Limited Settings: Can it be Done? Infectious Diseases Grand Rounds. University of Colorado Denver Health Sciences Center. Denver, CO, October 2008. Travel Medicine: A Potpourri and Travelogue. Coalition for Travel Health Practitioners. Denver, CO, October 2008. Treatment of TB in HIV-Infected Patients: Challenges in Management and Clinical Trial Design. FDA Anti-Infective Drugs Advisory Committee meeting. Silver Springs, MD, June 2009. Hepatitis C Infection in Colorado and Denver: Prevalence and Risk Factors in HIV- Infected Persons, MSM and IDU. CDC Consultants meeting: Acute Hepatitis C Virus Infection among HIV-Infected Men Who Have Sex with Men: Organizing a Research Consortium to Study an Emerging Public Health Problem. Boston, MA, October 2009. HIV/AIDS at Denver Public Health: A Blast from the Past and How it Shaped Our Future. HIV Care Conference. Denver, CO, March 2010. How We Got Here: Historical Perspective on HIV/AIDS in Colorado. HIV Over Fifty, AIDS Coalition for Education. Denver, CO, September 2010. Organizer, Tuberculosis: The Effect of Social Justice on a Global Epidemic. Special Session. 138th American Public Health Association Annual meeting. Denver, CO, November 2010. Global Epidemiology and HIV Policy. Tropical Medicine and Global Health Course. University of Colorado School of Public Health, Denver, CO, October 2011. Tuberculosis and HIV: Global Epidemiology, Transmission and Contact Evaluation. Tuberculosis and HIV: Clinical Manifestations and Diagnosis. Treatment of Tuberculosis: Principles of Therapy and Approach in Resource-Limited Settings. Treatment of HIV in Patients with Tuberculosis: Challenges in Management. Pulmonary Complications of HIV/AIDS. Pulmonary M. avium complex IRIS in an AIDS patient. Visiting Professor, Novel Education Clinical Trainees and Researchers (NECTAR) Program, University of Zimbabwe College of Health Sciences. Harare, Zimbabwe, November 2011. HIV/AIDS in Zimbabwe: The Good, the Bad and the Ugly. HIV Care Conference. Denver Public Health. Denver, CO, January 2012. The NECTAR Program in Zimbabwe: The View of the Visiting Professor. Infectious Diseases Grand Rounds, University of Colorado School of Medicine. Aurora, CO, February 2012. The History of HIV/AIDS in Colorado: Discovery, Controversy, Collaboration and Success. Community Educational Forum. Denver, CO, July 2012. Review of Optimal Timing Studies and Impact on Policy: An Update. WHO/TDR TB-HAART DSMC Meeting. Dar es Salaam, Tanzania, October 2012. The Global Tuberculosis Epidemic: Epidemiology, HIV/AIDS, and Multi-Drug Resistance. Tropical Medicine and Global Health Course. University of Colorado School of Public Health, Denver, CO, November 2012. HIV/AIDS in Zimbabwe: The Good, the Bad and the Ugly. Colorado Coalition of Travel Health Professionals. Denver, CO, January 2013. Tuberculosis and HIV: Global Epidemiology, Transmission and Contact Evaluation. Tuberculosis and HIV: Clinical Manifestations and Diagnosis. Treatment of Tuberculosis: Principles of Therapy and Approach in Resource-Limited Settings. Treatment of HIV in Patients with Tuberculosis: Challenges in Management. Drug-resistant Tuberculosis: Global Epidemiology, Diagnosis and Management. Public Health Workshop: Prevention of TB and TB Transmission. Pulmonary Complications of HIV/AIDS. Pulmonary M. avium complex IRIS in an AIDS patient. Visiting Professor, Novel Education Clinical Trainees and Researchers (NECTAR) Program, University of Zimbabwe College of Health Sciences. Harare, Zimbabwe, April-May 2013. Global Tuberculosis Epidemic: Role of HIV and International TB Control. TB Educational Conference. Denver Pubic Health. Denver, CO, June 2013 Opportunistic Illnesses-Decreased, but not Forgotten: Update on Prevention and Treatment of OIs. HIV Care Conference. Denver Public Health, Denver, CO, September 2013. University of Colorado-University of Zimbabwe Medical Education Partnership: View of the Visiting Professor. Global Health Lecture Series. University of Colorado Center for Global Health. Aurora, CO, October 2013. The History of the ID Fellowship at the University of Colorado: Who Are We, What We Have Done. ID Grand Rounds, University of Colorado School of Medicine, Aurora, CO April 2014 The Past, Present and Future of HIV/AIDS. 25th Denver STD/HIV Clinical Update. Denver CO, September 2014 TB and TB-HIV in Zimbabwe: Epidemiology, Treatment, Control and Research Activities. DPH TB Educational Forum, Denver, CO, September 2014 Virology, Epidemiology, Clinical Manifestations, Treatment and Infection Control of Ebola virus disease (multiple lectures). Ebola Treatment Centre, International Medical Corps, Lunsar, Sierra Leone, January, February 2015 TB and HIV Infection: Clinical Manifestations and Treatment. Ebola Treatment Centre, International Medical Corps, Lunsar, Sierra Leone, January 2015 Ebola Update. Psychosocial staff and Ebola Survivors. Ebola Treatment Centre, International Medical Corps, Lunsar and Makeni, Sierra Leone, February 2015 Fighting Ebola: Understanding What to Expect - From the Front Lines to your Front Door. Boulder County Health Department. Boulder, CO, March 2015 (with Drs. Michael Callahan and Charles Steinberg) The Ebola Epidemic in Sierra Leone: A day in the life of Grace and David. Infectious Disease Grand Rounds, University of Colorado School of Medicine, Aurora, CO, March 2015. (with Dr. Grace Marx) Ebola Virus Disease in Sierra Leone: Down but not Out, Report from the Field. Department of Medicine Grand Rounds, University of Colorado School of Medicine, Aurora, CO, March 2015. (with Dr. Grace Marx) Poster Discussion Facilitator, Latent Tuberculosis Infection. American Thoracic Society International Conference. Denver, CO, May 2015. Ebola Virus Disease in Sierra Leone: Down but not Out, Report from the Field. Days of Celebration. Denver Health, Denver, CO, June 2015 (with Dr. Grace Marx). Ebola Virus Disease in Sierra Leone: Down but not Out, Report from the Field. Denver Health High Risk Infection-Ebola Care Team. Denver CO, July 2015. Ebola Virus Disease in Sierra Leone: Reports from the Field. Colorado Department of Health, Denver, CO, July 2015 (with Dr. Grace Marx, Jessica Hancock-Allen). Tuberculosis Screening in the Elderly: Way to Accelerate TB Elimination? Korean Tuberculosis Advisory Board Meeting 2015. Seoul, South Korea, September, 2015 The Ebola Epidemic of 2014-2015: What happened, Lessons learned and Whats next? Bugs and Drugs Conference. University of Colorado. Aurora, Colorado, October 2015 Ebola Virus Disease in Sierra Leone: Reports from the Field. Public Health Emergency Preparedness Fall Regional Staff Meeting. Denver, CO, October 2015 (with Jessica Hancock-Allen) HIV-related Lymphoma: Epidemiology, Clinical manifestations, and Treatment. HIV Care Conference. Denver Public Health. Denver. CO. March 2016 (with Dr. Sonia Okuyama) The History of the ID Clinic: A Walk down Memory Lane. Denver Public Health ID Clinic Retreat. Denver, CO, July 2016 Adult HIV Infection. Physicians Assistant course. University of Colorado School of Medicine. Aurora, CO, March 2017 The History of HIV/AIDS in Colorado: Discovery, Controversy, Collaboration and Success. Department of Medicine Grand Rounds - Tim Gill Distinguished Lecturer. University of Colorado School of Medicine. Aurora, CO, September 2018 Moderator, Thematic Poster Session, Tuberculosis Diagnosis, American Thoracic Society International Conference, Dallas, TX. May 2019 Ebola Virus Disease in Africa: Take of Two Epidemics. Denver Medical and Pathological Society. Denver, CO, October 2019 (Rev 2/20)     PAGE 3 &'(18JY\oqr ! 4 5 6 7 B  s t $ > ɾɶɮɗɗɂyqihOJQJh{dOJQJh{d5OJQJhP[OJQJh7*hQR0JOJQJjhQROJQJUhQRhN %OJQJhN %OJQJhHkZOJQJhQRhQROJQJhQROJQJhG5OJQJhDH6OJQJhDH65OJQJh{dOJQJh{d5OJQJh{d)&'(89Z[\qrs6 7 B *`gdQR *` * *d` $ *da$ *dB C   M { | 5 r s t *d d *d` *ld`l *d^` *  $ % & > ? R }  *d`gdN% *` * *d` *d} ~ D/0q12MN *d`"%{`a03=>HJxh75OJQJh{d5OJQJhkhkOJQJhkOJQJh I/h I/OJQJh`|dOJQJh I/OJQJhOJQJhOJQJhhcOJQJhhIlOJQJh#oNOJQJh#qOJQJh2OJQJh{dOJQJhOJQJ/ Rb>HIKL *d^gd I/ *d^gdhc *d`6y6XZ"e *d`gd2 *d`gdQp *d`gdM " *d *d` *d`gdhIlcx15WXZa!*1eTXȯyyynfhrOJQJh2hhIlOJQJhhIlhhIlOJQJhhIlOJQJhOJQJh OJQJh2OJQJh2h2OJQJh{d5OJQJh0OJQJhR,lOJQJhQpOJQJhGOJQJh%)OJQJhOJQJhUtOJQJhn(OJQJh{dOJQJ(ef#7HY,[l *d`gdw *d` *d * *d`gdhIl *d`gd2'+RY KOPabmnj k E!O!!!a#b###1%A%J%]%A'I'''(())+Ǿh{d6OJQJhQOJQJhOJQJh2OJQJh^JOJQJhOJQJhhOJQJh5OJQJh{d5OJQJhrOJQJh9OJQJhGOJQJh0dOJQJh{dOJQJh0OJQJ3 P56|()o *d^` *hd`h * *h`h *d`gd9 *d`Cqr4bc: k m )!D!E!!!!!*" *hd`h *d`*"+"y""""""##O#]#^#####$$f$x$y$$$$(% *` *d8` *d`(%B%C%%%%)&g&q&r&&'''\'p'q'''')(C(D(( *` *d8`gd%r *`gd%r *d8`(((()))^)p)q))))E**** + +U++++++M, *d` *` *d8`++++++++R-o-----....///0j0k0002214M4i4k4r4s4w4x4@6]6(7r7s7t7u7v7~77𭢭Œ{sh(OJQJh7@OJQJh7h7@OJQJh7OJQJhd;lOJQJhhEnhhEnOJQJhhEnOJQJhDOJQJhQOJQJht<OJQJhDOJQJmH sH h+h{dOJQJmH sH h OJQJh{dOJQJhOJQJ-M,,,,!-"-p-z-{----R.p.q....-/o/p//000 *d8` *d`0j0000<1=1111 2N2O2222&3i3y3z333 41424x4y4 *d8`$ *d8`a$y4455Z5p5q5555 6 6^6666'7(777 *d8`gd7$ *d8]`a$gd7 *d8`gd>$ *d8`a$ *d8`77778 8'8488888P9Y999:: ;;<<< <)<*<`<}<<<*=.=====>>> >'>->>>ؿضخئ؞ؖ؎خ؆~sksh2OJQJh2h2OJQJh+B/OJQJh;OJQJhJ8OJQJh&@OJQJh(OJQJhOJQJht<OJQJh{d6OJQJh{dH*OJQJh?eOJQJhDOJQJh{dOJQJhOJQJh)RxOJQJh`OJQJh7OJQJ*778 8 8a8n8o8888%9&9p999:D:E::::;?;@;;; *d8`gd)Rx *d8`;;<E<F<~<<<<</=Y=Z====> >p>>>?@?A?$ $%*d8`a$gd2$ $%*d8`a$gdZ *d8`>>?>d>e>f>i>j>m>o>>>>>>>???? ?!?"???K?x???????@@f@@@@@@ŽŽťՊ}umuehOJQJh|OJQJh+OJQJh+B/h+OJQJ^Jh^JOJQJhDOJQJhcW(hcW(OJQJh+B/OJQJhcW(OJQJh\NCOJQJh;OJQJhcPOJQJh&%OJQJhd;lOJQJht<OJQJh2OJQJh2h2OJQJh?eOJQJ&A????@@t@@@AgAnAq` D%*d8^gd{$ D%*d8^a$gd$ 6$$'*d8^a$gd|$ *d8`a$gd$ $>+d8`a$gd|$ 0*d8`a$gd(9$ $%*d8`a$gdZ $%*d8`gdcW( @@@@ A A AAAAgAmAoAAAAAAAAAAAAABB맖yyqdZPHh&@OJQJhZ@OJQJh@OJQJh|}h|}@OJQJh|}OJQJh`OJQJh=!OJQJh;h;OJQJ^J hcPhcPCJOJQJ^JaJhOJQJh`hOJQJh;OJQJh;@OJQJh|@OJQJh]h@OJQJh?eOJQJhOJQJh7h6OJQJnAoAAAB>B?BBBBBBBACCCDDiD $*d8]^gdca $*d8]^gdZ$ *d8^a$gd$ $*d8`a$gdZ D%*d8^gd{BBB'B=B>B?BBBBBBBBBBBBCC6CE?EEEEEAFgFhFFFFFGGGGGHHSH $*d8]^gd}P $*d8]^gdZ"E1E=E>EEEEF9F@FPFQFfFgFhFiFFFFFFFFF9OJQJh=OJQJ)SHTHHHHHHMI~IIIJfJ)L*LLLLMMWMXMgd3m $*d8]^gd  $*d8]^gd $*d8]^gd}PIIIJJeJfJJJJJJJJKKL'L(L)L*L/L8L?LѺpdXMEMhnrOJQJhA(hA(OJQJhA(B*OJQJphh B*OJQJph$hkh 0J>*B*OJQJph'hkh 0J>*B*OJQJ\phhkh B*OJQJph&jhkh B*OJQJUph,hkh 5B*CJOJQJ^JaJph"""hkh 5OJQJhPRaOJQJh5OJQJh OJQJh h OJQJ?LBL\LwLxLyL~LLLLLLLLLLLLLLLLLLLL MMMMM#M/M6MqEqrrGrOrsssMvNvwwxxxxϸϰϧϟϧϧϧϧϧϧϗχϰϧh;]LOJQJhdOJQJhbOJQJhOJQJh*OJQJh{d6OJQJhhaUOJQJh@OJQJh+h{dOJQJmHsHh{dOJQJh{d5OJQJht>OJQJhOJQJh`OJQJhOJQJ/`+a,aaa0b1bbbcc(d)d eeeeZf[f&g'ghh )d )d )d` )vLd^v`Lh i iFjGjkkkkllmmnnooooppqqqrrr.s/s )d )vLd^v`L/s t tNtOtttuuMvNv0w1wwwxxxyyzz{{| v)vLd^v`L )d )vLd^v`Lxxx&ybyvyJz^z{{| |}}xy;NBYƒÃ6CDI ThںڲکڡڙڙډڲځhdOJQJhOJQJh)RxOJQJh;]LOJQJh&^OJQJhhaU5OJQJh-rOJQJhOJQJh+h{dOJQJmHsHh{d6OJQJh{dOJQJh+h)RxOJQJmH sH h+h{dOJQJmH sH 2||}}?~@~~~ƒʄ˄ )Pd^`P v)vLd^v`L )vLd^v`L )d|})*ۉ܉njȌ h)vLd^v`L v)vLd^v`Lgd )vLd^v`L )dՎ֎ˑ̑jk”xy?@ )d v)vLd^v`L )vLd^v`LEX:M_s !-/8:@BLNTV]_hjy{(-.67s)< ?JüôhOJQJh:OJQJ hiTnhiTnhiTnOJQJhiTnhiTnOJQJh{d;OJQJh;]LOJQJh{d6OJQJhhaUOJQJh{dOJQJD !78ל؜OP?@()() )vLd^v`LgdiTn )vLd^v`L=>ɩʩ֪תDExy )vLd^v`L ܵݵz{ )d )yE^y`Egdr )yEd^y`Egd" )vd^vgdTt )vLd^v`LIJŲȲɲ޲MNSTYZjkvw~óij&+,DEL\vYiݺ²ʲʪʲh\iOJQJhTtOJQJh^OJQJh@OJQJhPOJQJh=h{dOJQJhz06OJQJh=h=OJQJh{dOJQJhOJQJ?͵ٵܵ5BJLawz{ !"./45DEUV^_pַ˻óskhTtOJQJh+h{dOJQJmHsHh=h{dOJQJ^Jh{dOJQJh{d5OJQJhz06h!OJQJhqF3OJQJh!OJQJhz06OJQJhs]OJQJhrZOJQJhDH6hrZOJQJmHsHhDH6hTtOJQJmHsHhDH6hPOJQJmHsH*yzpq QR=>ԾվοϿij>? )d )vLd^v`L )yEd^y`Egd"0CQR˽޽67VW?TvwCXlx (*_t+,4vwyKLӽ¹ӵh^J5OJQJh{d5OJQJh+\h+h(Rh~hf-hp.GhCy{ h{dH*hdh{dH*OJQJh3dch{dh{dmH sH h)RxOJQJh{d6OJQJh{dOJQJhwOJQJ8?BC*+LMjk )vLd^v`Lgdr )d *)dgdr )vLd^v`L  *)dLWhijk$%IJUVt3@;<f刀xňpxphhjOJQJh+OJQJhJ2OJQJhcOJQJhsNUOJQJh;]LOJQJh{dOJQJmHnHuh+h{dOJQJmHsHh{d6OJQJhOJQJh^JOJQJh ]OJQJhh ]hOJQJh{dOJQJh ]5OJQJh{d5OJQJ(kab@A;<fgLM )dgdc )vLd^v`L *)dgd ]&AGJKLM !"| $^_`wͺ~ݔhUthT\OJQJhT\hT\OJQJhT\OJQJhUthUtOJQJhUtOJQJh]h]OJQJhhOJQJhOJQJh_OJQJh ]OJQJhcOJQJhjhjOJQJhjOJQJh]OJQJ1MN"#zxyu )dgd5 )vLd^v`Lgdc )vLd^v`Lgd}: )vLd^v`L)FHIfghtuvwxͶինՓՀՀՀՀuh4h-S%OJQJh-S%h-S%OJQJh-S%OJQJh}:hQMAOJQJhp|hc0JOJQJh4hcOJQJjhcOJQJUh4h4OJQJhQMAOJQJhcOJQJhQMAhQMAOJQJh:OJQJh}:OJQJhT\OJQJ. !".@BCUVcd,-ȧ뎆~skskskskskskhZOJQJhZhZOJQJh4OJQJh5OJQJh-S%OJQJhchchc0JOJQJjhchcOJQJUh-S%hcOJQJ h-S%h-S%hchcOJQJhp|hc0JOJQJh4hcOJQJhcOJQJjhcOJQJU*->?JKRSZtuxy8;`aD_kxpi^phQThQTOJQJ hQThQThQTOJQJh}:Jh}:JOJQJh}:JOJQJhk.hk.OJQJhk.OJQJ\hk.hk.OJQJ\hk.OJQJh!cOJQJh5OJQJhK9hZ0JOJQJjhZOJQJUhZ5OJQJh4OJQJhZOJQJhZhZOJQJ#`aklz{\]-.' )d^gd5  )d^gdj=P )d^gdk. )d^gd5(z 78OPYZ[\r $%'()+,-8:ͽŢŐŐŐ}uhPOJQJh$COJQJhyhyOJQJh5 h5 OJQJ h8Yh8Yh8Yh8YOJQJh8YOJQJhk.OJQJhYqOJQJh5 OJQJhj=Phj=POJQJhj=POJQJh4OJQJhH[OJQJhQTOJQJhyOJQJ.: '( %./1;Tsyz{|#$OPQmnźŲ|q|q|jq| h]Kph]Kph]Kph]KpOJQJh]KpOJQJhhOJQJhOJQJhU4OJQJhoUOJQJhHhHOJQJhHOJQJhF:hF:OJQJhF:OJQJh!cOJQJh/|h/|OJQJh/|OJQJh^OJQJhD]OJQJh$COJQJ)'( |}y{}Z[gh )vLd^v`L )d )dgd5 )d^gdH )d^gd5 npqtvwxyz{|}|~KMqǿqi`WhG5OJQJh#q5OJQJhz06OJQJhwh{dOJQJmHsHhwOJQJh;]LOJQJhvlOJQJh{dh{d6OJQJh{dOJQJh{d5OJQJhZ5OJQJh5OJQJhHOJQJhHhHOJQJhHh]KpOJQJhpOJQJh]KpOJQJh]Kph]KpOJQJh[\-.}LM9QR78 )dgdG )vLd^v`Lgdvl )d  *)d )vLd^v`L%&348?CDOPQOQXYZXY`ap{|ͽյݭhOJQJh-h-OJQJh-OJQJh+?aOJQJh#qh#qOJQJh#qOJQJh;]LOJQJhpOJQJhECOJQJh \OJQJh^OJQJh{dOJQJhOOJQJhGOJQJhGhGOJQJ28PYZabfHIxyVW )vLd^v`Lgd3dc )d^gd- )vLd^v`Lgd#q )vLd^v`Lgdr )vLd^v`L+,56GHXZeh%FGHhox0EVWʺº岪岟}uh;]LOJQJhP_OJQJh{dOJQJhhaU5OJQJh{d5OJQJh#qh#qOJQJh ?OJQJhOzOJQJhMXOJQJhHOJQJh>0OJQJh>0h>0OJQJh-OJQJhNQOJQJh-h-OJQJhOJQJ.JKLMxR[]gFGVW`bk&r{}/8:D <= 𽵪 h/ch/ch/cOJQJhhOJQJhOJQJh^JOJQJh{d6OJQJhOJQJhOJQJhP_hP_OJQJ hP_hP_h{dOJQJh*N;OJQJ9Wvw|}XY"#+,KL )d )vLd^v`L )Pd^`P v)vLd^v`L &(36>BIKLMRT]`im*+,JHJL-.;DEFNOcdʰh|hIOJQJhJsOJQJh|hI5OJQJhIOJQJh/c5OJQJhz065OJQJh{dOJQJh{d5OJQJh^JOJQJhOJQJh~VOJQJhhOJQJh/cOJQJh/ch/cOJQJ2KL-.:;GHWX} )d`gdI )dgdI )vLd^v`L dgd/c )ddy8FGUVW|~mopswx ¶|tltlt|c|t[t|Sh8YOJQJhOJQJh{d6OJQJhOJQJhEOJQJh{dOJQJh{d5OJQJh|hIOJQJ]hIOJQJh|hIH*OJQJhYi5OJQJh|hI5OJQJh|hYiOJQJ\h^]OJQJ\hYiOJQJ\hIOJQJ\h|hIOJQJ\h|hIOJQJ }~pq`a )d`gdr )d` )vLd^v`L )d`j <fgh]^ABRSwxĻzvh{dhwOJQJhz06OJQJhqxOJQJh`<OJQJh+h{dOJQJmHsHhCy{5OJQJh{d5OJQJhI5OJQJh|OJQJhMOJQJhUhUOJQJhUOJQJh{d6OJQJh{dOJQJh;]LOJQJ.]^RSKL (vLd^v`Lgdqx )vLd^v`L               *)d )vLd^v`L 9    5 6       u v     $%9:{|YZ`b6#7##hwOJQJh;]LOJQJhYOJQJhz06OJQJh!OJQJh)RxOJQJh+h{dOJQJmH sH h{d6OJQJh<99OJQJhqxOJQJh{dOJQJmH sH h{dOJQJh`<OJQJ7:; !BC9:ab$%{|89YZ )vLd^v`LZamn$%  m!n!["\"6#7#I$ )vLd^v`L##$$;%<%...///00445577P8Q8e8g8*9+99999i:|:::S;T;;;z<{<<<<E=F===r>s>>>I?J?@@vAwABBJCKCCCHDIDh{dOJQJmH sH hCy{OJQJh<99OJQJh;]LOJQJhq OJQJh+h{dOJQJmH sH hYOJQJhz06OJQJh{dOJQJh{d6OJQJ@I$J$;%<%1&2&)'*'(((())W*X*W+X+,,- - . ...// )vLd^v`L/0011h2i2V3W3 44 55556677f8q8r8H9I9::;; )vLd^v`L;;;<<h=i=>>a?b?6@7@XAYA>B?BlCmCjDkDDDEEFF H )vLd^v`LIDEE:FBFFFGG H!HHI=I>IIJKKkLlLLLMMvNwNOO*P+P7P8PQQRRRR\S^SSS;U*OJQJhCy{OJQJh{d6OJQJhq OJQJh{dOJQJ; H!HIIJJKKLLNN}P~PQQRRSS[U\U+V,V'W(WWW )vLd^v`LWXXYYZZ\\\\]]^^C`D`~?~~~ǿdzhvR8OJQJh{d5OJQJhz06hz06H*OJQJh OJQJhz06OJQJhQZOJQJhwOJQJhAOOJQJh (OJQJh{dH*OJQJh{dOJQJ@a|b|}}}}}}U~V~~~[\PQ9:   )d )vLd^v`L~stqrOPEY ABrs/0×ė&';ƚݚޚGHhrOJQJhShSOJQJhSOJQJhvR8OJQJhz06OJQJh{d6OJQJhOJQJhROJQJhQHOJQJh;qh{d6OJQJhTSOJQJh{dOJQJ8NOԄՄSTbcنچfgهڇPQՈֈ )vLd^v`Lֈr}~  fg VW )vd^vgd )vLd^v`LFG}~ܐݐ_`֑ב[\“Ó12./  )vLd^v`L  mnԖՖQRޗߗrsXYwx34ݜޜ )vLd^v`LHTZ̜͜xy\]z{pq`aVWno^_ rsST¯˯̯h_OJQJhTOJQJh)RxOJQJhOJQJh<99OJQJhCy{OJQJhe,OJQJhz06OJQJh$#OJQJhSOJQJhvR8OJQJh{dOJQJh{d6OJQJhS6OJQJ7ޜ  %&z{  abҢӢ:; )vLd^v`L;ͣΣST*+ !z{no )vLd^v`Lnors01"#ٲڲ}~ )vLd^v`L̯үӯٯگRa)*,.ln¶68ַط ϸѸcdٺҿԿh 8OJQJh{dH*OJQJh(9OJQJh<99OJQJhTOJQJhCy{OJQJh5'OJQJhuzOJQJh{d;OJQJh{d6OJQJh_OJQJh{dOJQJ>~)* mжѶuԷ13 )dgd! )d )vd^v )vLd^v`Lgd(9 )vLd^v`Lи   TUBC  ӿ )vLd^v`LRS,mn45st *d8`  *)d )vLd^v`L+-$%4/1t89@BCOPZ[_`fgrt!13HJ}Z[e13ëëëhjqBOJQJhz06OJQJhCy{OJQJh5'OJQJh{dH*OJQJh 8h(9h{dh 8OJQJh(9OJQJhTOJQJh{dOJQJCAFG2}~}~)*~\]89 *vLd8^v`L9dekH;BC v*vLd8^v`LgdjqB *d8`gd5' *vLd8^v`LjlGI45:<@Am,-= KQ KȵȭȥȥxxhvOJQJh!OJQJhCOJQJhghAz@(OJQJhAzOJQJhhbUOJQJhXjOJQJhhahhaOJQJhhaOJQJh4DOJQJh+gOJQJhEOJQJhvR8OJQJh(9OJQJhjqBOJQJhNOJQJ/C=>ABKL  23{| vL^v`Lgd*7 vL^v`Lgd6q v*yE^y`Egd%r v*vLd8^v`LgdjqBK no&'23_`ijmyz{|?JoȻvvvvlbhOvOJQJ^JhOJQJ^Jh*7h*7OJQJ^Jo(h*7OJQJ^JhY ;OJQJ^JhY hY ;OJQJ^JhkbOJQJ^JhY OJQJ^JhY hY OJQJ^JhY OJQJh6OJQJh+OJQJhAzOJQJhOJQJhCOJQJh'OJQJ%2BC/z!s"#uNO^gd1@^gduL*^gdr^gdOv vL^v`Lgd*7"#./0;@AB./ykZk!h1@h1@B*OJQJ^Jphh1@B*OJQJ^Jphh/B*OJQJ^JphhTSB*OJQJ^JphhGB*OJQJ^Jphh*7B*OJQJ^JphhuL*B*OJQJ^Jph$hOvhOvB*H*OJQJ^JphhkbB*OJQJ^JphhOvB*OJQJ^Jph!hOvhOvB*OJQJ^Jph/0F^yz !;<=>HPpqrtཹveWeeWhqB*OJQJ^Jph!hzhzB*OJQJ^Jphhqhq6OJQJ^JhqhqOJQJ^J hqhqhqOJQJ^JhTSOJQJ^JhqhHOJQJ^Jhq hHhHhTSB*OJQJ^Jphh1@B*OJQJ^Jph!h1@h1@B*OJQJ^Jphh.9B*OJQJ^Jph !"tuvw12NOS^bstǹǹǫǝǏssseh1@B*OJQJ^Jphh+gB*OJQJ^JphhB*OJQJ^JphhBB*OJQJ^JphhvR8B*OJQJ^JphhL4B*OJQJ^JphhB*OJQJ^JphhuL*B*OJQJ^JphhqB*OJQJ^JphhTSB*OJQJ^JphhzB*OJQJ^Jph#0fg56 U *vLd8^v`Lgd *vLd8^v`Lgd! *vLd8^v`Lgd/^gdT^gd1@'/0=>Xdefgkr &.23456l񶮣xmhhOJQJhOJQJh!h!OJQJh!OJQJhL4OJQJhTOJQJh/h/OJQJh/OJQJh/B*OJQJ^JphhvR8B*OJQJ^JphhB*OJQJ^Jph!hThTB*OJQJ^JphhTB*OJQJ^Jph) !,eyzr)*=>FHq&CDɾɮɐɐɈxh<;OJQJhOJQJhOJQJh,Qh,QOJQJh!OJQJh1h1OJQJh1OJQJhbOJQJhbhbOJQJhOJQJhh6OJQJhhOJQJh@"F Title$ *da$ 5OJQJbC@2b Body Text Indent  *vLd8^v`LOJQJH@BH rZ Balloon TextCJOJQJ^JaJ6U`Q6 P[ Hyperlink >*B*ph<^@b<  Normal (Web)CJaJFV`qF  FollowedHyperlink >*B*phPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]  !+7>>@B"EHI?LMUqY_xL-:n d#IDD`p~H̯K/D  !%)-12468:;<>?ACEFHJLORVY\^cgknprstvwy{|~B } e*"(%(M,0y47;A?nAiDSHXMSY\^`h/s|?k'h8W}ZI$/; HWeoa|ֈ ޜ;~9C    "#$&'(*+,./03579=@BDGIKMNPQSTUWXZ[]_`abdefhijlmoquxz} 4BC'DHf!BUcxXXXXXXX !!8@0(  B S  ? _Hlt374469649 _Hlt374469622 _Hlt374469623 _Hlt374469641CCCC@@@@CCCC FO $$%%G)J)q*v*6.;.)202F6K6J<O<ABBBHHCPMPR RTTXXXvYYYYYYYYZZZ[[[[[[[\\\\/]8]u]]]]D^J^[^a^'_._^_d___`"`O`V``` a&a+a4a+b1bGbMbzbbbbbbccccddddddddddeeeefffgguggggggJhii>iEiiiiiXj]j~jjjjkk kkkk1l4l5l;ldlsllllmJmSmoooooooooo0p6pvppppp&qoqvqqqr rWr^rlrrrsrxryr~rrrrrrrrrrsssssssttttputuuuxuyuuuuw wyyyyzz{{P{Y{| |||||||||||} }"}+}q~u~~~~~~~~~~~",1<!*}mzہ܁(56Aah4<'.hl‡ч؇HR_i݋ ގ,2>HekHNV[\afp‘ʑߒ #-18DL +BPWȕ͕ݕ)PZ_gltJRgtBIhpFM[d˝ԝ16anu{Ǟ˞ОԞ۞#\dޡ3;Ģ!äƤ̤'+,2diUWY]IQu|+04;?Fѫ׫x|ͬӬ !?Oͭϭ٭ݭ®ˮ!-4C֯گѰذ@Iűͱαձ [m37jqķOUWZKOOS&,GP^eֿܿEIEIXa@L<A-3msx}"*8=Z_cj{"178<IOPSbk| 'y=ARV^bW[cgrv~/3;? MR Z_dj)-S\<&2 29>C '.7C$0,2&@D  .2AOfn;B  g m     |6Onws|7?PV*0  l"s"""$$"%+% &&&'''))(,0,-#-..m/y/0"00000I1P1y1111-232(3035526>6666699;;==y>>??IAKABBBBDDDDDDDEFFFFFFFFFFvGGHHHHKKKKKLLLOOPPPPPQQRR RTTU UVV2V;VW%W4W=WDXX[p[z[[\\o\s\x\~\\\]]^^__DaIa dNdffffffffffgghhllcmemxx zzc~r~RYx'?K&5ҙ48MSCE!&,L _ '6S|)>oxC^r49cu:Cm+>^:y(*Ct)Pgir!\e D s !I!q!!!!E"j""""""" #,#-#H#U#l###M$Z$[$y$z$$$$$%% %%%R&U&&&-'9'''j(s(O*j*****&+0+i+l+ ,,y,,,,-"-Z-]---- . ./.^.x.y....002255p66778g89 9o99;;<"===A>Q>??fBBMFbFF)GzGGGGGXHZHmHoHHHHIIIGIII J6J8JdJfJxJJJJK K!KSKKKKKKL1L3LYL[LmLLLLM M3MOMMN$NANNNNNNaScSTT>UBU`UdUXX Y!Y&Y,YYYY#Z*ZZZZt[[[[ \\$\)\q\s\\] ]]Q]R]t]u]]]]?^O^V^_!___` ``aaa:bBbbbccc@dddeeeffffffgguggggJhhhiiiPjbjjjrjjjj"k(kkll0lDlIldlllllmmmmmnnAnIn#o+oroooooCpDpp&qqqqqirrr#sssss|tttuuuu2v5vwwxrx}xxxxydyyyyWzzzz4{5{{{{{|$|&|||"}}}}~~ !ZowaD„Ȅ{TdžІ|lj\e:`lsy(3:u|=ޒ-28ʔӔ 7q{Ȗ8BJP3:$ ")fo/8۠ߠġ_ڤ7?Xmt  G9:uۭݭb֯ް;]`NPz ɳEKfG̶϶7`d59T \w6=X $4Zwz08JU38Yap)K&LNbc#7 #uyW^auv`il'{ TZ]q%+$1;"#Usy nq<PX[G[c}9QY(BJCLRlm *28RS~JNQXX]=Cy+JQWrkrQpw}HKjL`aL`mSknIacz'=U^<!g >iBGM23q2x 4} jeoPQv-.e:q;jk % p      8 ? |   B  %|}7\9:Z)y(M])*O<*^<fg     N!s!"8"#8#X####$$%% &&&&'c'e'''v(w((Q)v)*@*L*O* +.+:+=+W++++++,,,,----R...... /g/h///6070Q01+111223333M4{4445F55,6-6s67J7b7788d88Y9s99:?:::;;K;<I<t<<<<<'===t>>L????MAAsBBhCC9DlDSFwF:H^HbIIzJJ\KKMdзryrs8 -/лѻ5X߼,-X8<q"Grs35~FGo *d&]ij9c12F.l{v >:dEI#Cfg"<>qYmv21>l{_s(EFvDmn:L{MO33333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333rr5TXKOgx klrr5TXKOgx kl{_>o^`CJOJQJo(^`CJOJQJo(pp^p`CJOJQJo(@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo({_ 8YXT *;H**@**0f2j~q{=`YH[uz A~kblnz8YEU|+7I%)1Np!YN3LEqpspx]{F>KyNG-)7%># ? l !-!K-!M "$#}m#$`$Jm$&%N %o#%N%-S%c%e%0&o'a (cW(e(f(n()/ * 5*uL*+m,k.L/+B/ I/ 0.F0I01O2S2qF3Wp3P4U4uq4g5an5z06DH6hH8J8vR8(9.9<99>9":O8:F:p^:}:;?-;<;B;*N;#<A<t<t<%)=5x=>T>L> @1@QMAbAKwAbBjqBC$CLC\NC4DEEGE3F_FhF^sF Gp.GKGWGHuFHQH IGI}:J]WJ^JfJ;rJ;]LMMi7M#oNOUuOuOtP P Pj=PcPqPQQc1QxQQR ReRTSQTvTzToUKUsNUhaUhbUVSWG|WMXhXZHkZrZL[\T\Kl\p\ ]^]]k ]D]%I^L^V^z^4_c_`+?aNIaPRacala #b!c/c3dchc{}c0d>d{d`|d'e?eKe neqeJf7]fof"$g[gYi>i\ii#jXjMAku+lR,ld;lhIlIl(xl3mlnnDnhEnPniTnkn*tn;o,p]Kpq0q#q6q;qYqr%r+rgGrnrAyr$ s@(tUt]to)uv|)v3w_wqx)Rx!axrxeyzazCy{|}1}#};*~{lEOPdF?RAz!@`T3 P["C)_Z "'+g|XW';QZ_9TW=]mk/|)SCJs w)mm#.;-Fww;!O/~VC[+eJ2Ruky6s]cy/2:`p{02i49N&@[$E}G05Y!LNQECXc4Bw2DyA(^2?Wwq 463~N}Pd5U=c5'C(L4AOdfS2`<J] jJ; \9VQ^PeQ 5,Q8YvN.'*|iz}@OOOO@Unknown G.[x Times New Roman5Symbol3. .[x ArialY5  z Courier (W1)Courier NewO1 CourierCourier New?= .Cx Courier NewQGreek SymbolsSymbol5. .[`)TahomaA$BCambria Math"AhՂgՂgI.I.!43QHP?2!xx CURRICULUM VITAEvaleriedcohn Oh+'0P     $08@HCURRICULUM VITAEvalerieNormaldcohn3Microsoft Office Word@Ik@_ԟ@P9@"E:.I՜.+,D՜.+,H hp  Denver Health CURRICULUM VITAE Titlel 8@ _PID_HLINKSA$*V&http://www.healthpolicysolutions.org/http://t.co/01XuVeL6$b http://ow.ly/bqwHdE^ %http://www.pulmonaryreviews.com/blogE^%http://www.pulmonaryreviews.com/blog|$!https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&ved=0CC4QFjAA&url=http%3A%2F%2Fwww.niaid.nih.gov%2FABOUT%2FORGANIZATION%2FDMID%2FPages%2Fdefault.aspx&ei=hdenUrCeIYaiqQGk-YHAAg&usg=AFQjCNEXhRZTNjyvOtiVs3G5fNLH0T7Rqg&sig2=vfL8N9DBWaC7iEp0taz5lQ&bvm=bv.57799294,d.aWM=^mailto:david.cohn@dhha.org  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F`aV:1Table#~WordDocumentDSummaryInformation(DocumentSummaryInformation8CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q